hg_103684.1

Basic information about the TSS

---

TSS ID: hg_103684.1 Species: human Chr: chr10		Start: 6202924 End: 6202941 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000379775.9 ENST00000640683.1 L77662 AK291263 BC040482 Distance: 0 GeneID: 5209 HGNC/MGI_ID: HGNC:8874 UniProt_ID: A0A1W2PR17 Q16875

Gene_name: 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 Gene_symbol: PFKFB3 Gene_synonyms: Gene_source: HGNC:8874

TATA-Box annotation

---

Distance to TSS:	1
Nearest PromoterID:	NM_001363545
Entrez ID:	5209
Nearest Unigene:	Hs.195471
Nearest Refseq:	NM_004566
Nearest Ensembl:	ENSG00000170525
Gene Name:	6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3
Gene Alias:	IPFK2|PFK2|iPFK-2
Gene Description:	6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3
Gene Type:	protein-coding
CpG%:	0.12
GC%:	0.721393
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):	-34(CTCTTTAAAAGC,-,0.00),-33(TCTTTAAAAGCC,+,0.00)

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@PFKFB3 p2@PFKFB3 p3@PFKFB3 p4@PFKFB3 p5@PFKFB3
Sample		p1@PFKFB3	p2@PFKFB3	p3@PFKFB3	p4@PFKFB3	p5@PFKFB3
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	22.99	6.43	0.19	0.39	4.09
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	22.46	7.89	0.00	0.20	5.06
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	18.90	6.75	0.19	0.39	4.05
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	23.08	7.28	0.21	0.62	3.12
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	25.87	9.67	0.00	0.45	2.70
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	19.77	6.59	0.39	0.19	3.29
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	17.65	6.54	0.00	0.65	5.66
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	19.14	5.57	0.00	0.24	3.88
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	22.23	5.77	0.00	0.64	4.27
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	47.53	4.06	0.58	0.00	4.64
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	40.02	2.02	0.00	0.40	3.64
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	43.50	3.66	0.00	0.00	4.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	32.24	13.54	0.16	1.45	6.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	23.91	8.12	0.75	0.90	4.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	33.15	14.05	0.66	0.22	4.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	29.93	10.31	0.75	1.26	2.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	29.27	8.74	0.44	0.66	2.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	24.47	10.97	1.27	0.84	2.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	24.53	10.66	0.53	4.80	2.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	45.43	11.58	0.00	2.71	4.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	45.58	10.56	1.20	4.14	2.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	51.96	12.60	1.04	1.73	2.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	42.27	15.25	0.90	2.07	2.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	44.41	16.02	0.73	3.15	2.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	49.79	14.19	1.55	1.29	2.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	47.16	12.98	0.32	0.95	3.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	40.11	12.09	3.30	4.95	2.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	69.55	16.50	1.41	0.47	2.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	47.33	13.08	1.94	0.81	1.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	51.21	18.10	1.09	0.36	2.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	35.59	13.19	1.67	0.42	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	39.27	14.85	1.17	1.37	1.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	28.49	16.88	1.90	1.27	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	17.65	8.08	0.99	0.49	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	29.54	11.78	1.68	0.56	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	36.98	16.67	1.34	0.57	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	14.31	7.97	1.23	0.61	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	12.49	11.08	0.00	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	12.69	9.99	0.54	0.00	1.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	8.88	6.48	0.72	0.24	1.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	12.00	8.94	0.00	0.94	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	7.03	3.95	0.15	0.59	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	10.33	5.69	0.21	0.84	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	10.84	8.57	0.52	0.87	2.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	13.65	8.83	0.40	0.40	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	14.42	6.75	0.47	0.70	3.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	17.03	8.64	0.48	0.96	1.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	15.20	5.36	0.00	0.60	2.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	24.42	8.86	0.96	1.44	2.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	21.64	7.48	0.81	1.21	2.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	22.13	9.02	1.23	1.43	2.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	28.91	8.89	0.89	0.67	2.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	26.97	10.29	0.35	1.77	1.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	20.88	7.62	0.66	1.66	2.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	3.36	0.00	0.84	0.00	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	8.27	1.84	0.00	0.46	1.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	30.14	9.08	0.65	1.62	3.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	21.20	9.64	0.00	1.61	3.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	10.06	2.20	0.31	2.20	2.83
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	25.38	14.10	0.00	1.41	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	29.16	14.58	0.00	0.00	2.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	7.17	3.18	1.59	0.00	1.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	15.97	4.08	1.02	1.70	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	26.64	13.32	0.65	1.62	3.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	20.59	12.42	1.42	0.71	2.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	0.00	0.00	0.00	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	13.65	18.53	0.00	0.98	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	11.90	16.36	0.00	0.99	1.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	15.01	12.67	0.00	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	6.29	3.64	0.33	0.33	2.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	5.57	14.85	0.31	0.00	2.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	7.64	15.90	0.00	0.00	3.67
Adipocyte - breast, donor1	11376-118A8	4.43	5.23	0.00	0.00	0.48
Adipocyte - breast, donor2	11327-117E4	49.09	6.74	0.80	0.64	1.93
Adipocyte - omental, donor1	11473-119C6	16.16	7.51	0.13	0.00	0.89
Adipocyte - omental, donor2	11474-119C7	14.95	8.22	0.75	0.00	5.98
Adipocyte - omental, donor3	11475-119C8	42.53	7.37	0.67	0.00	1.34
Adipocyte - perirenal, donor1	11476-119C9	17.86	5.74	0.00	0.64	1.28
Adipocyte - subcutaneous, donor1	11259-116F8	38.48	3.30	0.00	0.00	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	6.32	3.16	0.00	0.00	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	32.50	4.87	0.00	0.00	2.95
Adipocyte differentiation, day04, donor1	13019-139D4	39.11	15.06	0.00	0.00	5.08
Adipocyte differentiation, day04, donor2	13022-139D7	77.99	19.56	0.26	0.77	2.06
Adipocyte differentiation, day04, donor3	13025-139E1	30.66	18.40	0.00	0.84	3.35
Adipocyte differentiation, day04, donor4	13028-139E4	27.63	19.99	0.59	0.00	2.94
Adipocyte differentiation, day08, donor1	13020-139D5	140.28	14.80	0.48	0.24	5.63
Adipocyte differentiation, day08, donor2	13023-139D8	52.29	13.88	0.00	0.97	3.87
Adipocyte differentiation, day08, donor3	13026-139E2	41.06	10.13	0.53	1.07	1.60
Adipocyte differentiation, day08, donor4	13029-139E5	29.49	6.12	0.00	0.00	3.90
Adipocyte differentiation, day12, donor1	13021-139D6	196.72	9.98	1.66	0.00	8.32
Adipocyte differentiation, day12, donor2	13024-139D9	55.51	10.80	0.75	0.25	3.01
Adipocyte differentiation, day12, donor3	13027-139E3	81.81	16.36	0.33	0.00	4.25
Adipocyte differentiation, day12, donor4	13030-139E6	77.94	9.13	0.30	0.00	2.74
Alveolar Epithelial Cells, donor1	11510-119G7	35.36	25.86	0.22	0.00	2.65
Alveolar Epithelial Cells, donor2	11590-120G6	52.71	12.91	0.72	0.00	2.15
Alveolar Epithelial Cells, donor3	11671-122G6	17.97	14.38	0.00	0.00	3.59
Amniotic Epithelial Cells, donor1	11533-120A3	3.24	3.96	0.00	0.18	1.98
Amniotic Epithelial Cells, donor2	11613-122A2	3.35	3.35	0.00	0.00	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	4.11	5.55	0.00	0.00	1.85
Anulus Pulposus Cell, donor1	11248-116E6	7.09	8.24	0.00	0.00	0.80
Anulus Pulposus Cell, donor2	11463-119B5	8.33	10.78	0.00	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	14.83	6.29	0.00	0.00	0.90
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	5.64	6.51	0.00	0.00	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	4.28	0.00	0.00	0.00	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	20.92	7.77	0.30	0.00	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	6.32	6.32	1.26	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	3.96	5.94	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	14.29	5.85	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	10.19	9.22	0.00	0.49	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	5.34	4.16	0.59	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	9.42	4.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	9.43	1.45	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	6.27	6.27	0.00	0.00	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	4.94	7.74	0.00	0.00	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	4.09	4.09	0.00	0.00	2.73
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	5.28	5.73	0.00	0.00	0.90
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	11.79	6.43	0.00	0.54	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	7.75	6.80	0.00	0.38	0.76
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	4.01	4.54	0.00	0.00	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	22.44	9.75	0.00	0.00	1.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	6.47	4.64	0.00	0.00	0.50
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	6.00	3.60	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	17.70	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	6.18	7.72	0.00	0.17	1.37
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	12.58	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	8.25	2.43	0.00	0.00	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	9.11	6.83	0.00	0.00	1.90
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	8.48	3.63	0.00	0.00	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	5.70	3.99	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	7.91	4.70	0.00	0.00	0.64
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	4.65	4.65	0.00	0.00	1.81
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	6.10	4.69	0.00	0.47	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	6.43	5.14	0.00	0.00	1.93
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	2.14	5.71	0.00	0.00	2.85
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	6.43	3.51	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	6.62	4.82	0.00	0.00	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	5.94	4.75	0.00	2.38	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	8.65	3.56	0.51	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	7.64	6.88	0.25	0.25	0.76
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	6.99	5.08	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	8.20	7.34	0.00	0.43	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	9.95	5.93	0.00	0.21	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	8.12	6.38	0.00	0.00	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	13.23	5.67	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	15.26	6.27	0.00	0.17	1.53
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	11.58	2.32	2.32	0.00	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	2.11	6.34	0.00	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	12.86	7.29	0.00	0.00	0.86
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	11.43	6.62	0.60	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	13.12	5.83	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	7.59	7.59	0.00	0.00	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	12.75	7.65	0.00	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	6.36	5.59	0.00	0.00	1.27
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	11.97	9.91	0.00	0.00	1.03
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	7.96	7.65	0.00	0.00	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	9.56	6.69	0.00	0.00	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	10.20	11.53	0.22	0.00	0.67
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	4.58	6.10	1.53	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	7.75	8.86	0.00	0.00	1.66
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	11.12	9.27	0.00	0.26	1.85
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	9.09	6.91	0.00	0.36	1.09
Astrocyte - cerebellum, donor1	11500-119F6	35.00	12.77	0.12	0.12	1.35
Astrocyte - cerebellum, donor2	11580-120F5	20.20	17.80	0.17	0.17	3.42
Astrocyte - cerebellum, donor3	11661-122F5	37.34	15.10	0.21	0.00	3.57
Astrocyte - cerebral cortex, donor1	11235-116D2	45.66	9.76	0.00	0.35	4.53
Astrocyte - cerebral cortex, donor2	11316-117D2	36.24	23.78	0.00	0.32	5.50
Astrocyte - cerebral cortex, donor3	11392-118C6	46.54	18.50	0.45	0.75	3.43
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	35.67	41.40	0.11	0.46	4.93
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	20.42	39.46	0.13	0.00	5.39
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	24.47	40.06	0.34	0.00	4.32
Basophils, donor1	12241-129G9	163.98	13.08	1.31	0.00	3.14
Basophils, donor2	12242-129H1	129.89	16.60	0.36	0.36	2.89
Basophils, donor3	12243-129H2	219.17	27.05	0.59	0.15	1.62
Bronchial Epithelial Cell, donor1	11511-119G8	15.31	7.33	0.43	0.00	1.29
Bronchial Epithelial Cell, donor2	11591-120G7	23.77	10.06	0.00	0.00	1.83
Bronchial Epithelial Cell, donor3	11672-122G7	21.52	14.35	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	25.11	10.04	0.00	0.00	1.26
Bronchial Epithelial Cell, donor5	11457-119A8	22.46	11.65	0.21	0.21	2.91
Bronchial Epithelial Cell, donor6	11461-119B3	6.22	5.07	0.00	0.00	3.68
Bronchial Epithelial Cell, donor7	11769-123I5	12.24	6.48	0.00	0.00	0.90
Burkitt's lymphoma cell line:DAUDI	10422-106C8	28.75	14.74	0.21	0.93	10.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	31.67	13.74	0.23	1.16	7.92
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	8.95	19.51	0.00	0.00	0.96
CD133+ stem cells - cord blood derived, pool1	12223-129E9	0.00	10.34	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	557.36	70.44	1.13	3.94	14.65
CD14+ Monocytes, donor2	11305-117B9	577.22	55.68	1.48	15.96	11.32
CD14+ Monocytes, donor3	11381-118B4	627.44	60.81	1.10	15.59	14.27
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	56.61	30.29	0.28	0.57	4.25
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	64.44	22.37	0.00	0.38	9.48
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	39.45	36.49	0.33	0.33	5.92
CD14+ monocytes - mock treated, donor1	11863-125A9	108.12	88.75	2.75	0.58	1.59
CD14+ monocytes - mock treated, donor2	11873-125C1	100.18	75.74	1.21	1.81	2.11
CD14+ monocytes - mock treated, donor3	11883-125D2	135.50	103.05	1.18	1.90	2.61
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	180.96	92.07	3.01	2.18	1.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	150.70	70.93	1.93	2.21	3.86
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	210.49	75.62	2.48	2.23	0.99
CD14+ monocytes - treated with BCG, donor1	11860-125A6	189.73	88.50	3.13	1.96	2.55
CD14+ monocytes - treated with BCG, donor2	11870-125B7	172.00	106.47	2.31	1.42	1.25
CD14+ monocytes - treated with BCG, donor3	11880-125C8	189.77	69.86	1.74	1.74	1.31
CD14+ monocytes - treated with Candida, donor1	11868-125B5	486.98	119.40	5.85	3.51	6.09
CD14+ monocytes - treated with Candida, donor2	11878-125C6	480.51	135.18	5.81	3.70	4.75
CD14+ monocytes - treated with Candida, donor3	11888-125D7	465.93	87.64	4.44	6.66	4.44
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	176.56	87.46	5.95	2.08	1.93
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	126.31	80.42	2.20	1.00	1.80
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	116.80	69.54	1.04	1.87	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	602.39	213.91	11.44	4.12	2.75
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	366.22	147.94	3.39	2.94	2.26
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	662.98	168.47	10.48	3.93	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	77.74	75.32	2.42	1.34	1.61
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	142.19	110.08	4.19	0.70	2.27
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	118.67	83.32	0.84	2.52	3.37
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	533.86	172.32	9.00	5.51	3.12
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	418.14	171.55	1.76	2.11	2.82
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	566.83	191.28	7.46	3.07	1.75
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	136.53	61.38	3.49	3.66	2.62
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	184.72	89.95	4.09	6.69	2.23
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	179.12	67.04	1.94	3.45	1.51
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	362.40	114.25	4.91	4.50	2.05
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	266.80	95.50	1.85	0.46	2.09
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	306.00	85.37	3.02	2.78	3.48
CD14+CD16+ Monocytes, donor1	11789-124B7	157.59	23.32	1.74	2.40	2.83
CD14+CD16+ Monocytes, donor2	11801-124D1	164.93	29.57	1.39	2.08	3.93
CD14+CD16+ Monocytes, donor3	11912-125G4	224.20	27.94	1.73	1.08	4.77
CD14+CD16- Monocytes, donor1	11788-124B6	139.99	44.07	1.40	2.34	4.05
CD14+CD16- Monocytes, donor2	11799-124C8	125.22	41.04	1.57	1.22	2.27
CD14+CD16- Monocytes, donor3	11910-125G2	122.86	42.81	0.67	0.67	2.90
CD14-CD16+ Monocytes, donor1	11790-124B8	173.52	23.73	1.02	0.77	3.06
CD14-CD16+ Monocytes, donor2	11800-124C9	92.22	16.47	0.88	1.98	1.98
CD14-CD16+ Monocytes, donor3	11911-125G3	125.70	19.58	0.63	1.05	4.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	2.03	22.36	0.00	0.00	14.23
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	2.71	18.31	0.00	0.00	14.92
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	0.00	21.75	0.00	0.00	23.82
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	3.73	15.46	0.00	0.53	4.26
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	0.00	12.87	0.00	0.00	17.69
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	3.51	19.65	0.00	0.70	18.95
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	2.35	15.69	0.00	0.00	18.04
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	1.32	18.46	0.00	0.00	27.68
CD19+ B Cells, donor1	11544-120B5	31.23	16.44	0.00	2.47	4.93
CD19+ B Cells, donor2	11624-122B4	113.17	15.96	1.45	0.00	2.90
CD19+ B Cells, donor3	11705-123B4	81.28	18.17	1.01	0.50	5.05
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	1.62	4.85	0.00	0.00	18.59
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	1.60	2.40	0.00	0.00	16.38
CD34+ Progenitors, donor1	11545-120B6	158.64	37.15	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	300.57	64.05	1.69	1.12	2.81
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	5.64	16.53	0.00	0.00	1.13
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	1.13	13.75	0.00	0.00	1.35
CD4+ T Cells, donor1	11225-116C1	67.13	39.63	0.36	0.71	3.93
CD4+ T Cells, donor2	11306-117C1	113.90	40.42	1.22	4.90	8.57
CD4+ T Cells, donor3	11382-118B5	172.93	34.77	0.91	2.74	2.13
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	1.53	22.97	0.00	0.00	3.57
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	0.67	29.20	0.00	0.00	4.72
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	1.15	30.47	0.00	0.00	5.46
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	145.07	32.71	0.47	0.95	5.69
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	69.53	36.52	0.00	1.40	5.62
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	32.96	42.85	0.00	0.00	13.18
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	9.83	17.92	0.14	0.00	2.02
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	6.27	21.18	0.00	0.34	3.05
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	8.06	23.54	0.16	0.32	2.74
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	95.94	28.24	0.00	1.34	1.79
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	62.89	26.90	0.00	0.35	3.49
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	21.56	21.12	0.00	0.44	2.64
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	15.60	23.19	0.00	1.26	1.69
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	12.47	29.92	0.00	0.62	2.08
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	14.37	30.41	0.00	0.67	2.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	28.55	28.83	0.27	1.63	5.44
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	16.08	31.09	0.00	0.54	7.50
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	8.97	34.07	0.00	0.00	3.59
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	9.83	23.36	0.19	0.00	2.78
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	5.20	19.06	0.00	0.65	4.77
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	5.04	26.06	0.00	0.21	1.89
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	68.26	27.81	0.51	0.51	5.56
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	58.06	35.53	0.43	0.00	2.17
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	25.71	22.66	0.00	0.44	1.74
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	4.45	40.08	0.49	0.00	14.35
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	4.62	28.62	0.00	0.00	14.77
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	5.58	25.12	0.00	0.00	19.54
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	5.26	32.68	0.55	0.00	11.08
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	4.66	32.15	0.00	0.00	12.02
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	10.78	46.20	0.00	0.00	10.78
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	6.09	33.30	0.36	0.36	16.47
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	6.92	22.16	0.00	0.00	19.39
CD8+ T Cells, donor1	11226-116C2	152.89	27.50	0.98	3.27	3.27
CD8+ T Cells, donor2	11307-117C2	167.44	23.28	0.75	2.63	5.26
CD8+ T Cells, donor3	11383-118B6	144.93	27.27	1.01	3.28	7.32
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	13.30	34.41	0.00	0.46	1.61
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	9.83	28.76	0.24	0.96	3.59
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	8.21	18.06	0.00	0.00	2.19
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	11.71	23.72	0.30	0.00	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	11.52	28.56	0.72	0.24	0.72
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	15.69	31.38	0.23	0.23	2.27
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	13.69	28.25	0.22	0.22	1.96
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	9.21	26.85	0.00	0.26	0.79
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	10.32	28.38	0.47	0.47	2.35
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	17.81	31.09	0.00	0.60	1.51
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	13.36	28.18	1.16	0.00	2.32
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	24.25	30.37	0.27	0.27	1.33
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	196.11	32.39	0.00	2.63	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	168.51	36.89	0.91	2.73	3.64
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	181.99	24.61	0.75	5.97	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	16.57	34.21	0.00	0.00	1.44
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	16.11	33.09	0.29	0.58	1.15
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	17.21	29.93	0.00	0.24	2.83
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	16.48	28.52	0.00	0.00	2.85
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	15.69	30.76	0.00	0.31	1.54
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	14.75	27.25	0.00	0.00	1.28
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	19.89	32.13	0.00	0.00	2.29
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	16.95	30.74	0.00	0.00	1.18
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	15.13	34.04	0.00	0.00	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	196.72	17.67	0.00	2.41	7.23
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	195.84	27.98	0.70	8.39	10.49
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	237.41	28.05	0.00	8.01	5.01
Cardiac Myocyte, donor1	11525-119I4	9.14	3.66	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	8.40	2.47	0.00	0.00	1.98
Cardiac Myocyte, donor3	11686-122I3	24.31	8.73	0.00	0.00	0.53
Chondrocyte - de diff, donor1	11261-116G1	8.67	5.20	0.00	0.00	1.39
Chondrocyte - de diff, donor2	11338-117F6	12.44	4.98	0.36	0.00	1.78
Chondrocyte - de diff, donor3	11410-118E6	13.65	3.87	0.11	0.34	0.91
Chondrocyte - re diff, donor2	11339-117F7	18.80	6.27	0.00	0.00	0.90
Chondrocyte - re diff, donor3	11411-118E7	77.24	10.11	0.00	0.40	1.21
Ciliary Epithelial Cells, donor1	11242-116D9	5.39	12.05	0.00	0.00	4.36
Ciliary Epithelial Cells, donor2	11323-117D9	5.77	7.05	0.00	0.00	2.57
Ciliary Epithelial Cells, donor3	11399-118D4	6.55	7.52	0.18	0.00	3.27
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	54.65	22.74	0.28	0.09	5.87
Corneal Epithelial Cells, donor1	11526-119I5	3.51	7.69	0.00	0.00	1.54
Corneal Epithelial Cells, donor2	11606-120I4	9.10	6.83	0.00	0.00	4.55
Corneal Epithelial Cells, donor3	11687-122I4	5.11	7.92	0.00	0.00	3.83
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	0.33	16.01	0.00	0.00	3.30
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	0.95	14.19	0.32	0.00	4.10
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	0.00	3.45	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	1.19	12.63	0.11	0.00	2.38
Dendritic Cells - plasmacytoid, donor1	11228-116C4	243.59	27.67	1.02	1.02	1.71
Dendritic Cells - plasmacytoid, donor2	11309-117C4	206.96	21.54	0.00	0.00	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	234.71	30.97	0.48	0.48	0.97
Endothelial Cells - Aortic, donor0	11207-116A1	18.18	14.84	0.00	0.00	3.50
Endothelial Cells - Aortic, donor1	11263-116G3	21.12	18.78	0.00	0.59	1.76
Endothelial Cells - Aortic, donor2	11340-117F8	29.69	22.91	0.00	0.00	1.70
Endothelial Cells - Aortic, donor3	11412-118E8	11.01	12.58	0.00	0.00	2.75
Endothelial Cells - Artery, donor1	11264-116G4	9.60	15.13	0.29	0.00	1.16
Endothelial Cells - Artery, donor2	11341-117F9	13.65	17.18	0.24	0.00	2.35
Endothelial Cells - Artery, donor3	11413-118E9	27.00	19.46	0.00	0.18	3.86
Endothelial Cells - Lymphatic, donor1	11236-116D3	10.20	14.63	0.00	0.00	2.88
Endothelial Cells - Lymphatic, donor2	11317-117D3	8.82	10.04	0.00	0.00	2.13
Endothelial Cells - Lymphatic, donor3	11393-118C7	15.50	20.30	0.28	0.00	0.85
Endothelial Cells - Microvascular, donor1	11265-116G5	7.73	10.70	0.00	0.00	2.67
Endothelial Cells - Microvascular, donor2	11342-117G1	3.12	26.03	0.00	0.00	2.08
Endothelial Cells - Microvascular, donor3	11414-118F1	5.39	9.93	0.00	0.00	0.85
Endothelial Cells - Thoracic, donor1	11266-116G6	8.00	46.41	0.00	0.00	2.00
Endothelial Cells - Thoracic, donor2	11343-117G2	15.20	12.58	0.00	0.00	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	4.35	16.77	0.00	0.12	4.10
Endothelial Cells - Umbilical vein, donor2	11324-117E1	3.69	11.30	0.00	0.00	8.47
Endothelial Cells - Umbilical vein, donor3	11400-118D5	4.40	13.43	0.00	0.00	3.54
Endothelial Cells - Vein, donor1	11267-116G7	25.03	13.65	0.00	0.00	2.28
Endothelial Cells - Vein, donor2	11344-117G3	23.05	25.15	0.00	0.00	2.10
Endothelial Cells - Vein, donor3	11416-118F3	20.57	23.71	0.00	0.00	1.88
Eosinophils, donor1	12244-129H3	182.96	30.49	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	1613.96	191.43	1.65	19.80	1.65
Eosinophils, donor3	12246-129H5	2025.96	156.94	3.57	17.83	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	20.03	11.97	0.00	0.00	0.73
Esophageal Epithelial Cells, donor2	11587-120G3	12.48	14.56	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	14.78	2.46	0.00	0.82	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	5.26	2.30	0.00	0.00	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	7.58	4.01	0.11	0.00	0.54
Fibroblast - Aortic Adventitial, donor1	11245-116E3	7.40	4.37	0.12	0.12	0.73
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	30.57	5.87	0.14	0.14	6.69
Fibroblast - Aortic Adventitial, donor2	11326-117E3	8.54	5.38	0.21	0.00	1.37
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	29.77	6.59	0.26	0.53	7.90
Fibroblast - Aortic Adventitial, donor3	11401-118D6	17.94	6.98	0.00	0.00	3.32
Fibroblast - Cardiac, donor1	11268-116G8	14.06	6.35	0.00	0.45	1.36
Fibroblast - Cardiac, donor2	11345-117G4	15.16	22.74	0.00	0.00	1.52
Fibroblast - Cardiac, donor3	11417-118F4	9.94	8.83	0.16	0.00	0.47
Fibroblast - Cardiac, donor4	11452-119A3	6.06	7.27	0.00	0.00	3.03
Fibroblast - Cardiac, donor5	11456-119A7	8.12	17.01	0.13	0.00	3.30
Fibroblast - Cardiac, donor6	11460-119B2	4.24	9.70	0.15	0.15	3.64
Fibroblast - Choroid Plexus, donor1	11492-119E7	5.36	9.65	0.27	0.00	1.47
Fibroblast - Choroid Plexus, donor2	11572-120E6	8.20	6.90	0.00	0.00	1.73
Fibroblast - Choroid Plexus, donor3	11653-122E6	10.25	16.11	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	8.76	18.22	0.00	0.00	6.92
Fibroblast - Conjunctival, donor3	11692-122I9	3.73	7.63	0.00	0.00	2.54
Fibroblast - Dermal, donor1	11269-116G9	0.70	7.51	0.00	0.00	1.41
Fibroblast - Dermal, donor2	11346-117G5	7.55	11.79	0.00	0.00	4.72
Fibroblast - Dermal, donor3	11418-118F5	1.09	7.25	0.12	0.00	0.60
Fibroblast - Dermal, donor4	11450-119A1	5.65	11.53	0.34	0.00	4.18
Fibroblast - Dermal, donor5	11454-119A5	6.63	11.17	0.17	0.00	4.88
Fibroblast - Dermal, donor6	11458-119A9	7.15	13.81	0.16	0.00	2.92
Fibroblast - Gingival, donor1	11237-116D4	4.37	12.08	0.00	0.00	4.79
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	10.48	7.60	0.00	0.00	3.93
Fibroblast - Gingival, donor2	11318-117D4	5.67	16.21	0.00	0.40	4.88
Fibroblast - Gingival, donor3	11394-118C8	9.67	10.35	0.10	0.10	4.35
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	37.40	13.51	0.00	0.00	2.08
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	17.97	9.51	0.18	0.00	1.41
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	12.63	9.35	0.00	0.00	3.59
Fibroblast - Gingival, donor6 (control)	11922-125H5	9.87	6.76	0.00	0.00	4.19
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	10.23	7.41	0.00	0.00	3.53
Fibroblast - Gingival, donor7 (control)	11924-125H7	7.31	8.92	0.15	0.44	3.95
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	4.77	7.64	0.00	0.00	1.64
Fibroblast - Gingival, donor8 (control)	11926-125H9	10.97	15.36	0.00	0.00	1.10
Fibroblast - Gingival, donor9 (control)	11927-125I1	89.51	8.66	0.44	2.20	3.96
Fibroblast - Lung, donor1	11270-116H1	4.08	17.67	0.00	0.00	4.08
Fibroblast - Lung, donor2	11347-117G6	2.98	14.92	0.00	0.00	2.98
Fibroblast - Lung, donor3	11419-118F6	2.11	15.83	0.00	0.00	2.32
Fibroblast - Lymphatic, donor1	11506-119G3	2.50	14.99	0.00	0.00	1.67
Fibroblast - Lymphatic, donor2	11586-120G2	0.00	5.59	0.00	0.00	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	1.12	7.28	0.00	0.00	0.28
Fibroblast - Mammary, donor1	11540-120B1	6.50	12.99	0.00	0.00	6.50
Fibroblast - Mammary, donor2	11620-122A9	3.99	27.96	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	14.35	19.01	0.19	0.39	2.13
Fibroblast - Periodontal Ligament, donor2	11319-117D5	6.22	17.29	0.00	0.00	6.52
Fibroblast - Periodontal Ligament, donor3	11395-118C9	12.24	12.55	0.31	0.31	3.67
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	9.54	8.40	0.00	0.00	1.14
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	2.70	6.48	0.00	0.00	2.70
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	15.77	9.16	0.00	0.00	3.36
Fibroblast - Pulmonary Artery, donor1	11250-116E8	10.39	10.50	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	15.04	14.02	0.41	0.00	1.63
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	9.35	14.70	0.00	0.00	2.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	7.51	3.56	0.00	0.00	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	57.75	11.71	0.20	1.19	1.59
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	14.39	2.13	0.36	0.00	3.55
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	13.40	5.12	0.00	0.20	0.79
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	30.99	9.63	0.60	0.60	6.62
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	15.22	8.20	0.22	0.22	2.05
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	38.72	6.33	0.51	1.01	9.87
Fibroblast - skin normal, donor1	11553-120C5	6.56	3.45	0.00	0.16	1.15
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	56.74	6.22	0.20	1.40	1.80
Fibroblast - skin normal, donor2	11561-120D4	29.33	4.12	0.20	0.10	1.21
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	44.13	14.81	0.00	0.30	5.14
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	7.79	5.47	0.08	0.08	1.49
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	14.53	7.52	0.00	0.00	2.22
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	30.54	6.57	0.00	0.99	3.94
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	12.46	7.03	0.11	0.21	1.28
Fibroblast - skin walker warburg, donor1	11554-120C6	20.75	11.81	0.00	0.00	2.36
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	3.45	1.10	0.00	0.00	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	29.63	11.33	0.00	1.74	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	8.84	2.25	0.17	0.00	0.52
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	9.63	6.51	0.00	0.00	1.82
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	14.56	7.67	0.00	0.00	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	19.14	14.55	0.00	0.00	2.30
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	13.40	10.21	0.00	0.64	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	28.53	9.70	0.29	1.71	0.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	48.53	29.78	0.83	1.38	1.93
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	81.06	11.87	0.00	4.34	6.16
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	30.91	15.06	0.00	2.18	1.78
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	40.18	29.87	0.26	3.44	3.70
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	85.12	12.39	0.33	3.26	6.85
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	31.84	10.17	0.44	0.88	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	37.31	10.60	0.00	0.71	4.38
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	21.30	10.10	0.00	0.00	2.22
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	24.98	10.21	0.00	0.54	2.42
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	31.59	20.07	0.12	0.62	1.86
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	31.84	16.89	0.42	0.14	2.49
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	15.04	14.03	0.00	0.00	1.63
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	26.70	14.38	0.00	0.00	2.28
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	34.50	14.20	0.25	0.75	2.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	47.87	15.52	0.22	0.22	4.15
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	14.48	12.41	0.00	0.00	2.07
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	24.64	16.85	0.16	0.32	3.02
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	21.00	11.39	0.45	0.67	1.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	26.21	16.94	0.00	0.81	3.23
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	25.62	14.42	0.17	0.34	2.88
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	15.69	14.10	0.27	0.09	1.77
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	18.31	18.11	0.73	0.10	2.50
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	16.74	13.83	0.17	0.00	2.39
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	30.32	16.49	0.11	0.11	2.99
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	18.64	14.23	0.25	0.42	2.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	19.81	11.84	0.41	0.00	2.86
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	21.46	15.06	0.00	0.00	2.27
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	29.75	19.72	0.35	0.12	2.42
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	29.85	15.01	0.17	0.00	2.84
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	13.01	14.33	0.00	0.00	1.76
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	11.68	20.79	0.00	0.12	3.69
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	37.77	16.53	0.16	0.16	2.43
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	9.30	16.68	0.32	0.64	3.21
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	42.36	18.57	0.09	0.28	1.42
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	28.16	18.03	0.16	0.00	1.90
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	15.51	17.94	0.00	0.00	1.22
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	34.92	16.73	0.31	0.10	1.57
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	25.25	17.34	0.22	0.00	1.98
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	15.99	14.87	0.28	0.28	4.49
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	11.94	19.72	0.46	0.19	1.11
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	9.63	17.92	0.27	0.00	1.34
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	7.34	19.74	0.15	0.00	0.61
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	9.20	15.03	0.39	0.00	0.65
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	7.59	15.18	0.00	0.27	0.81
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	7.74	13.09	0.00	0.00	1.84
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	16.01	15.13	0.22	0.00	1.75
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	8.93	22.81	0.00	0.00	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	9.76	12.53	0.00	0.26	0.92
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	11.90	12.71	0.00	0.00	0.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	11.44	19.82	0.25	0.00	0.76
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	13.14	12.14	0.00	0.40	4.18
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	12.17	13.10	0.00	0.31	5.70
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	15.75	15.75	0.20	0.00	4.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	14.39	13.14	0.00	0.31	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	9.61	11.30	0.28	0.00	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	21.68	19.83	0.00	0.92	2.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	27.22	9.90	0.00	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	21.27	11.22	0.00	0.00	1.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	12.84	28.88	0.00	0.00	3.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	27.82	19.13	1.74	1.74	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	17.90	11.72	0.33	0.00	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	9.47	17.71	0.41	0.82	1.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	26.66	6.66	3.33	0.00	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	16.78	14.26	0.28	0.00	3.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	14.38	15.69	0.33	0.00	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	20.97	14.26	0.84	0.84	5.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	20.04	16.86	0.32	0.95	5.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	17.66	13.59	0.00	0.00	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	18.79	14.62	0.00	0.00	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	28.63	18.33	0.00	0.57	1.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	26.93	11.54	0.30	0.00	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	40.66	15.25	1.69	3.39	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	30.65	18.64	0.41	0.00	1.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	24.39	11.05	0.00	0.23	1.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	26.34	36.88	0.00	0.00	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	18.07	9.23	0.38	0.38	2.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	21.84	14.99	0.33	0.00	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	22.07	18.06	0.67	0.00	3.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	17.34	20.80	0.00	0.77	4.62
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	42.45	33.21	1.37	0.34	4.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	14.91	37.27	0.00	0.00	9.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	18.40	19.35	0.00	0.00	5.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	13.88	25.95	0.00	1.21	4.22
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	18.82	20.35	0.00	0.00	6.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	17.95	17.95	0.00	1.60	3.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	14.80	23.68	0.00	0.49	4.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	24.79	33.05	1.18	0.00	16.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	17.50	19.84	0.58	0.00	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	14.48	18.87	0.88	0.00	3.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	41.54	33.91	0.00	2.54	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	26.86	24.47	0.60	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	43.67	19.41	0.00	0.00	1.46
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	78.75	0.00	0.00	0.00	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	51.56	1.25	0.00	0.42	0.83
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	96.70	3.37	0.00	0.00	4.50
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	5.39	2.22	0.00	0.00	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	1.25	2.51	0.00	0.00	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	1.04	6.27	0.12	0.00	3.37
Hep-2 cells mock treated, biol_rep2	11899-125E9	1.01	5.74	0.17	0.00	1.86
Hep-2 cells mock treated, biol_rep3	11900-125F1	1.82	6.60	0.00	0.23	1.82
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	1.75	5.25	0.00	0.00	2.95
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	2.58	7.95	0.00	0.00	4.30
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	1.51	5.17	0.00	0.00	3.01
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	1.74	4.61	0.12	0.00	2.74
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	0.86	3.60	0.17	0.00	2.06
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	2.24	5.13	0.00	0.00	1.92
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	8.95	7.28	0.00	0.00	2.80
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	19.48	18.61	0.00	0.00	3.03
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	15.86	10.58	0.00	0.00	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	6.35	9.17	0.35	0.00	1.76
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	7.27	7.99	0.00	0.00	1.45
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	2.10	5.42	0.00	0.00	0.52
Hepatocyte, donor1	11523-119I2	20.58	1.21	0.00	1.21	2.42
Hepatocyte, donor2	11603-120I1	52.79	15.08	0.00	0.00	4.31
Hepatocyte, donor3	11684-122I1	44.79	6.14	0.61	1.23	1.84
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	29.37	18.28	0.00	1.96	5.87
Intestinal epithelial cells (polarized), donor1	11246-116E4	4.89	14.33	0.00	0.35	12.23
Iris Pigment Epithelial Cells, donor1	11530-119I9	24.70	5.90	0.00	0.14	0.96
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	0.00	35.02	0.00	0.00	12.74
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	26.70	0.00	0.00	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	27.08	0.00	0.00	27.08
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	4.15	11.08	0.00	0.00	12.46
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	2.50	17.52	0.00	0.00	12.51
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	11.87	0.00	0.00	11.87
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	5.13	20.50	0.00	0.00	15.38
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	4.57	13.71	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	4.87	29.24	0.00	0.00	14.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	6.67	25.01	0.00	0.00	11.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	0.00	7.26	0.00	0.00	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	1.32	19.85	0.00	0.00	10.59
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	2.22	15.52	0.00	0.00	11.09
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	0.00	41.91	0.00	0.00	5.24
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	2.52	30.23	0.00	0.00	6.93
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	0.00	26.29	0.00	0.00	13.92
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	14.63	0.00	0.00	14.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	0.00	15.50	0.00	0.00	12.92
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	1.61	16.10	0.00	0.00	11.27
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	23.90	0.00	0.00	23.90
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	0.00	23.63	0.00	0.00	7.33
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	0.42	18.89	0.00	0.00	6.72
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	28.74	0.00	0.00	14.37
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	1.61	22.50	0.00	0.00	4.82
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	0.00	11.08	0.00	0.00	11.08
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	60.32	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	0.00	8.50	0.00	0.00	8.02
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	0.00	9.07	0.00	0.00	9.07
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	14.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	1.08	19.37	0.00	0.00	9.69
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	0.00	16.52	0.00	0.00	17.79
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00	0.00	16.43
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	0.64	13.39	0.64	0.00	16.58
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	0.00	12.76	0.00	0.00	10.94
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	31.61
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	0.71	15.71	0.00	0.71	10.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	3.32	3.32	0.00	0.00	23.23
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	20.85
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	0.00	13.27	0.00	0.00	8.64
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	0.00	17.56	0.00	0.00	15.80
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	0.00	28.29	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	0.70	22.95	0.00	0.00	13.91
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	2.21	55.33	0.00	0.00	6.64
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	3.24	12.97	0.00	0.00	6.48
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	0.87	16.57	0.00	0.00	11.34
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	0.00	29.25	0.00	0.00	9.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	6.97	48.78	0.00	0.00	13.94
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	2.13	30.94	0.00	0.00	16.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	1.39	16.63	0.00	0.00	15.24
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	0.00	19.95	0.00	0.00	14.25
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	0.00	22.09	0.00	0.00	19.33
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	0.00	33.28	0.00	0.00	9.08
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	18.63	68.30	0.00	0.00	6.21
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	1.06	26.43	0.00	0.00	9.52
Keratinocyte - epidermal, donor1	11272-116H3	13.06	3.84	0.08	0.08	0.57
Keratinocyte - epidermal, donor2	11349-117G8	3.51	3.51	0.00	0.00	1.76
Keratinocyte - epidermal, donor3	11421-118F8	7.95	10.41	0.00	0.00	1.14
Keratinocyte - oral, donor1	11251-116E9	4.65	15.89	0.00	0.00	3.63
Keratocytes, donor1	11527-119I6	12.03	33.01	0.34	0.00	6.53
Keratocytes, donor2	11607-120I5	21.09	35.15	0.00	0.00	3.52
Keratocytes, donor3	11688-122I5	5.14	11.07	0.00	0.20	1.19
Krukenberg tumor cell line:HSKTC	10687-109F3	6.59	2.20	0.00	0.00	4.40
Lens Epithelial Cells, donor1	11529-119I8	15.10	9.71	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	24.57	6.00	0.00	0.00	2.65
Lens Epithelial Cells, donor3	11690-122I7	7.77	5.95	0.00	0.00	0.71
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	4.62	21.11	0.00	0.12	1.54
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	7.81	14.79	0.00	0.00	1.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	5.51	19.68	0.00	0.16	2.20
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	3.76	18.82	0.00	0.54	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	8.19	20.17	0.00	0.32	1.26
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	4.74	15.42	0.11	0.00	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	9.44	23.39	0.00	0.00	1.23
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	13.65	19.72	0.25	0.00	2.02
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	8.02	18.58	0.14	0.00	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	8.70	26.50	0.00	0.00	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	10.66	20.94	0.58	0.00	1.94
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	10.74	14.07	0.19	0.00	0.74
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	9.06	28.92	0.35	0.00	1.05
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	8.11	19.56	0.24	0.24	1.91
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	8.65	21.15	0.41	0.14	1.65
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	11.39	30.80	0.31	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	10.60	20.58	0.31	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	6.59	25.98	0.37	0.00	1.46
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	9.22	28.96	0.00	0.33	1.65
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	10.25	23.14	0.00	0.00	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	8.21	26.64	0.50	0.00	1.49
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	11.64	26.67	0.00	0.00	1.45
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	8.08	20.20	0.00	0.00	1.35
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	6.66	21.50	0.15	0.00	1.51
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	5.70	24.88	0.00	0.00	1.04
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	12.35	24.08	0.00	0.21	0.84
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	5.71	18.04	0.15	0.00	2.26
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	7.57	24.08	0.00	0.00	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	9.78	22.58	0.00	0.00	1.32
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	5.30	14.00	0.00	0.00	1.06
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	3.88	24.23	0.00	0.00	1.94
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	7.28	12.57	0.00	0.00	0.99
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	6.81	13.26	0.12	0.00	1.24
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	3.70	22.21	0.00	0.00	2.96
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	6.42	16.80	0.00	0.25	0.99
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	5.64	11.41	0.00	0.00	1.24
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	6.11	19.30	0.00	0.00	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	5.78	24.04	0.30	0.00	1.52
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	5.04	17.08	0.14	0.00	2.52
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	5.69	23.11	0.36	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	6.30	17.94	0.00	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	4.51	15.41	0.00	0.00	1.71
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	4.66	23.63	0.00	0.00	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	9.47	20.25	0.33	0.00	2.29
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	6.12	18.13	0.00	0.00	1.18
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	4.70	22.65	0.25	0.00	1.98
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	6.66	16.14	0.00	0.00	0.77
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	6.86	15.22	0.30	0.00	1.49
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	27.19	13.60	0.00	0.00	18.13
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	33.75	9.21	0.77	0.00	14.58
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	28.95	10.39	0.00	0.00	9.65
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	33.43	19.04	0.00	0.00	17.77
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	38.68	16.88	0.00	0.00	7.03
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	40.16	14.01	0.00	1.87	14.94
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	19.06	13.91	0.00	1.55	8.24
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	54.72	20.22	1.19	1.19	11.89
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	30.99	13.57	0.00	0.00	6.56
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	23.85	16.87	0.29	0.58	4.65
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	30.16	16.66	0.00	0.00	4.05
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	35.77	24.79	0.00	0.00	7.99
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	33.38	23.11	0.51	1.03	11.81
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	29.64	22.58	0.00	0.00	5.29
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	23.32	13.99	0.00	0.00	4.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	19.36	26.49	0.00	1.02	12.23
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	27.21	17.88	0.00	0.00	6.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	17.95	21.73	0.57	0.19	8.50
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	32.52	20.25	0.00	1.23	9.20
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	38.32	39.14	1.63	0.00	8.97
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	18.95	17.49	0.21	0.83	6.46
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	11.49	18.50	0.28	0.00	3.92
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	34.00	26.79	0.00	0.00	14.42
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	19.45	21.77	0.58	0.29	6.68
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	12.26	16.14	0.00	0.60	6.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	21.02	15.49	0.55	0.55	7.75
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	30.05	24.74	0.35	0.71	8.84
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	25.08	14.75	0.37	0.74	11.80
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	36.84	18.42	0.00	0.00	14.97
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	42.98	23.79	0.00	0.38	15.73
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	18.68	15.85	0.00	1.70	9.62
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	27.90	10.67	0.82	0.00	10.67
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	33.44	20.79	0.45	0.45	9.94
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	20.83	9.34	0.00	1.44	10.05
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	23.15	8.96	0.00	0.00	8.96
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	22.67	13.75	0.00	0.74	14.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	16.37	9.91	0.00	0.00	6.89
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	27.40	7.71	0.00	0.00	7.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	26.32	12.66	0.00	0.33	9.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	19.91	16.29	0.00	0.00	10.86
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	20.62	17.77	0.00	0.00	10.66
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	21.31	12.37	0.00	0.34	10.31
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	18.25	10.73	0.00	0.54	6.44
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	15.49	12.79	0.00	0.67	11.45
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	24.82	13.33	0.37	0.37	11.85
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	11.63	9.30	0.00	0.00	13.96
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	37.02	10.58	1.06	0.00	12.69
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	30.81	19.21	0.00	0.80	11.20
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	44.34	23.99	0.00	0.73	10.90
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	62.09	28.36	1.53	1.53	19.93
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	44.39	22.69	0.00	1.97	13.81
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	39.52	20.70	0.94	1.88	3.76
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	67.38	30.67	0.00	0.50	14.08
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	41.91	24.78	0.00	1.35	9.91
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	30.98	41.31	0.00	5.16	8.61
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	51.21	38.30	0.00	1.34	9.35
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	42.23	38.32	0.39	0.39	10.95
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	27.05	30.35	0.00	1.98	7.92
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	51.89	33.21	0.00	0.52	8.82
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	33.26	38.07	0.44	0.88	8.75
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	22.92	31.31	0.56	1.12	5.03
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	46.37	36.66	0.00	1.32	6.62
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	38.19	42.81	0.00	0.00	7.33
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	25.82	37.47	0.00	0.51	4.05
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	42.78	34.60	0.00	0.00	5.29
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	29.02	26.64	0.40	0.00	7.55
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	33.42	52.26	0.61	0.61	6.68
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	33.20	43.58	0.00	0.00	4.15
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	28.50	33.44	0.00	1.90	6.46
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	27.89	44.41	0.52	2.07	5.16
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	29.02	48.37	0.00	0.00	7.26
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	34.23	34.54	0.32	0.63	11.41
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	52.24	44.25	0.53	1.07	14.39
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	55.17	44.82	0.00	1.15	7.47
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	54.51	38.05	0.51	1.54	10.28
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	29.71	32.54	0.00	2.12	9.20
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	44.26	36.32	0.57	1.13	10.21
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	34.95	33.70	0.42	0.42	14.56
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	26.62	28.19	0.00	3.92	5.48
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	40.08	29.23	0.42	1.25	10.44
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	44.61	21.84	0.46	0.93	13.47
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	54.19	26.76	0.00	1.34	14.05
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	71.11	24.59	0.00	1.07	10.69
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	69.91	19.80	0.81	0.81	16.97
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	53.23	17.44	0.00	0.00	12.85
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	48.90	19.56	0.00	1.78	15.11
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	62.69	23.93	0.00	0.00	16.53
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	51.38	23.01	0.00	0.77	9.97
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	54.72	15.32	0.00	1.64	10.40
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	61.03	12.47	0.89	0.45	13.36
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	49.13	20.54	0.00	0.78	15.86
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	60.34	21.88	0.00	0.00	21.22
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	47.81	18.71	0.00	0.00	12.47
Macrophage - monocyte derived, donor1	11232-116C8	73.16	26.89	0.23	0.46	3.19
Macrophage - monocyte derived, donor2	11313-117C8	5.69	24.04	0.37	0.00	1.84
Macrophage - monocyte derived, donor3	11389-118C3	54.14	30.41	0.13	0.26	1.97
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	7.97	1.59	0.00	0.00	0.53
Mallassez-derived cells, donor2	11929-125I3	4.28	4.28	0.00	0.00	1.43
Mallassez-derived cells, donor3	11930-125I4	8.20	4.86	0.00	0.00	1.81
Mammary Epithelial Cell, donor1	11273-116H4	6.38	3.69	0.00	0.00	1.59
Mammary Epithelial Cell, donor2	11350-117G9	9.84	7.82	0.00	0.00	0.58
Mammary Epithelial Cell, donor3	11422-118F9	26.94	8.48	0.00	0.25	3.49
Mast cell - stimulated, donor1	11487-119E2	0.00	19.66	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	2.16	17.52	0.00	0.11	3.89
Mast cell, donor2	11565-120D8	60.92	28.83	0.00	1.19	5.94
Mast cell, donor3	11566-120D9	135.30	45.02	0.45	0.45	8.33
Mast cell, donor4	11567-120E1	49.46	39.00	0.18	0.71	3.01
Mast cell, expanded and stimulated, donor5	11940-126A5	2.44	17.08	0.00	0.00	3.55
Mast cell, expanded and stimulated, donor8	11942-126A7	2.33	15.18	0.00	0.00	1.75
Mast cell, expanded, donor5	11939-126A4	2.52	18.13	0.00	0.11	2.29
Mast cell, expanded, donor8	11941-126A6	18.75	28.45	0.00	1.00	2.18
Melanocyte - dark, donor1	11502-119F8	1.19	18.11	0.00	0.00	0.40
Melanocyte - dark, donor2	11582-120F7	9.00	3.46	0.00	0.00	0.69
Melanocyte - dark, donor3	11663-122F7	2.90	18.47	0.00	0.00	1.30
Melanocyte - light, donor1	11274-116H5	4.94	17.87	0.24	0.00	2.35
Melanocyte - light, donor2	11351-117H1	4.09	13.65	0.00	0.00	3.41
Melanocyte - light, donor3	11423-118G1	7.81	16.48	0.00	0.00	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	7.50	21.66	0.10	0.10	0.94
Melanocyte, donor2 (MC+2)	12739-135I3	2.96	13.98	0.00	0.27	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	4.02	8.57	0.00	0.00	0.54
Meningeal Cells, donor1	11493-119E8	11.17	17.24	0.00	0.00	2.98
Meningeal Cells, donor2	11573-120E7	21.57	16.29	0.00	0.00	1.76
Meningeal Cells, donor3	11654-122E7	9.29	9.94	0.00	0.00	0.82
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	1.71	5.13	0.00	0.00	2.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	5.13	6.14	0.10	0.10	0.40
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	3.94	7.88	0.00	0.00	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	2.62	14.39	0.00	0.00	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	3.59	9.33	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	5.72	9.11	0.00	0.00	2.54
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	5.03	6.53	0.00	0.00	3.02
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	1.54	8.35	0.00	0.44	4.40
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	2.92	10.96	0.00	0.00	4.38
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	2.25	8.18	0.00	0.00	3.07
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	8.17	5.26	0.00	0.00	1.25
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	2.97	9.66	0.00	0.00	1.86
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	14.34	9.60	0.13	0.26	1.97
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	0.59	5.93	0.00	0.00	0.89
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	2.34	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	3.84	10.89	0.00	0.00	1.28
Mesenchymal stem cells - adipose, donor0	11217-116B2	2.84	10.28	0.00	0.00	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	15.95	10.32	0.00	0.00	1.25
Mesenchymal stem cells - umbilical, donor0	11214-116A8	7.26	11.61	0.00	0.00	2.90
Mesothelial Cells, donor1	11247-116E5	5.30	3.18	0.27	0.00	0.27
Mesothelial Cells, donor2	12156-128G5	2.50	3.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	4.77	2.75	0.14	0.07	0.36
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	13.50	27.01	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	44.08	29.06	0.25	0.00	3.45
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	15.02	25.91	0.59	0.00	2.94
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	17.29	51.86	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	49.59	16.12	0.62	0.00	0.93
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	14.52	21.57	0.00	0.21	0.62
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	13.90	27.79	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	87.84	20.52	0.50	0.25	1.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	33.51	20.95	0.00	0.00	1.86
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	19.47	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	98.36	15.85	0.61	0.61	1.42
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	49.10	33.66	1.19	0.79	1.19
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	94.07	119.72	0.00	0.00	8.55
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	135.40	19.47	0.88	2.65	5.31
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	77.51	23.94	0.76	0.00	1.90
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	85.53	44.74	1.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	206.92	23.13	1.91	3.40	1.49
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	43.28	23.02	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	215.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	276.00	21.46	0.89	2.68	1.79
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	68.74	21.80	0.00	0.00	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	373.44	33.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	389.15	25.34	4.01	4.77	2.51
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	135.00	24.24	0.48	0.48	2.61
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	270.36	53.63	0.55	0.00	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	578.84	26.25	4.84	2.76	1.38
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	201.50	32.81	1.26	0.42	1.26
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	437.62	40.97	1.83	0.41	1.63
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	438.09	24.46	3.43	1.72	1.93
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	258.75	29.79	1.11	0.67	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	206.37	51.59	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	563.09	30.88	3.50	0.88	1.31
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	241.82	29.40	0.51	0.00	1.01
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	294.95	54.68	0.00	1.66	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	565.60	38.05	2.72	1.36	3.26
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	277.91	36.17	0.59	1.76	0.59
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	307.47	56.70	1.09	2.18	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	679.02	32.68	2.40	3.36	1.44
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	313.38	45.63	8.00	3.20	2.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	654.07	57.59	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	817.94	54.06	8.01	2.50	1.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	269.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	527.97	36.69	0.00	0.00	2.04
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	728.26	53.43	4.38	1.75	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	343.24	58.49	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	576.35	58.28	0.00	0.00	2.56
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	740.53	62.97	4.71	3.22	0.99
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	281.14	50.10	0.70	0.00	1.39
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	638.65	83.98	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	524.10	51.28	3.08	2.74	1.03
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	305.89	44.64	0.44	0.00	4.81
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	395.93	60.72	0.00	0.00	2.49
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	456.46	53.87	3.93	3.09	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	265.59	46.55	0.42	0.00	1.25
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	441.72	58.86	0.00	0.00	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	537.87	49.47	6.03	2.71	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	197.84	44.66	1.25	0.42	1.67
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	440.35	43.31	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	444.23	36.94	0.00	1.85	2.77
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	184.96	35.29	0.57	0.00	1.71
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	326.94	37.59	1.11	0.28	0.97
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	416.71	40.17	3.37	3.11	2.59
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	170.30	37.75	0.43	0.00	1.29
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	342.37	38.11	0.00	0.00	2.54
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	386.72	39.77	2.67	1.33	3.74
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	212.22	38.31	0.30	0.60	2.39
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	284.63	33.19	0.42	0.42	1.13
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	374.25	40.45	5.41	3.82	1.59
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	158.55	31.62	0.22	0.66	2.43
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	346.97	43.61	1.14	0.00	1.90
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	380.42	35.80	3.69	2.56	1.99
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	170.83	37.61	1.23	1.47	0.98
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	358.42	47.57	0.65	0.00	1.96
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	300.50	41.16	2.94	0.59	0.88
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	175.30	42.67	0.58	0.86	1.15
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	178.05	38.74	0.82	0.00	2.47
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	249.84	36.93	0.60	0.30	2.68
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	120.54	15.07	3.77	3.77	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	73.07	16.04	1.78	0.00	3.56
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	176.44	12.16	1.64	1.64	0.99
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	86.26	11.57	2.10	0.00	2.10
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	75.71	22.14	0.59	0.00	1.19
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	60.54	23.28	0.00	0.00	1.86
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	128.06	18.40	1.50	0.00	0.75
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	41.55	24.77	0.53	0.27	2.13
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	101.45	16.63	0.45	0.23	1.13
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	103.88	24.31	0.74	0.00	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	173.32	16.12	4.03	1.47	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	99.56	12.44	7.78	4.67	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	59.86	12.29	0.00	0.53	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	150.69	15.46	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	227.24	20.20	4.04	2.02	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	26.98	21.08	0.00	0.00	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	242.43	5.45	0.00	5.45	2.72
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	75.02	1.91	0.00	0.00	3.18
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	102.04	1.62	0.00	1.62	1.62
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	129.90	6.04	0.00	4.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	1667.37	91.36	0.00	11.42	17.13
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	427.38	16.31	0.00	13.05	32.62
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	280.40	19.01	0.00	9.50	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	928.63	37.65	0.00	50.20	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	6.25	7.76	0.00	0.00	1.29
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	3.66	6.27	0.00	1.05	1.57
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	10.68	7.34	0.00	0.67	1.33
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	12.52	9.18	0.00	0.00	0.83
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	15.97	3.80	0.19	0.19	1.90
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	20.75	12.77	0.00	0.00	4.79
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	11.56	4.08	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	1.84	11.03	0.00	0.00	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	11.72	7.53	0.00	0.00	0.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	6.51	3.49	0.00	0.70	0.93
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	8.92	5.67	0.00	0.00	1.08
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	6.10	4.20	0.00	0.00	1.05
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	6.45	4.47	0.00	0.99	2.48
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	4.06	2.44	0.00	0.00	1.62
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	6.12	5.67	0.00	1.13	1.59
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	6.70	5.39	0.16	0.33	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	8.38	5.47	0.00	0.18	3.83
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	14.85	6.37	0.00	1.06	1.59
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	18.61	10.81	0.00	2.40	1.80
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	1.64	0.00	0.00	0.00	0.98
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	9.59	5.53	0.00	0.33	1.46
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	6.88	5.82	0.18	0.18	3.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	17.58	7.74	0.00	1.41	2.81
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	8.27	4.14	0.00	0.92	0.92
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	9.64	8.68	0.00	0.64	0.96
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	6.90	2.76	0.00	0.34	1.03
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	7.80	3.34	0.00	0.00	2.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	6.77	6.35	0.00	1.27	3.39
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	6.41	3.56	0.00	0.71	0.71
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	10.73	6.44	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	10.66	4.33	0.00	0.00	1.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	8.57	4.51	0.00	0.00	2.25
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	3.57	3.57	0.00	0.40	1.59
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	10.22	5.57	0.00	0.93	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	4.92	4.92	0.38	0.38	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	8.15	7.17	0.00	0.00	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	8.72	7.41	0.00	0.00	1.74
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	7.24	1.36	0.00	0.00	2.26
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	9.70	4.41	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	10.64	7.98	0.00	0.00	1.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	17.86	8.43	0.00	0.99	3.47
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	7.66	3.45	0.00	0.38	1.91
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	10.59	5.75	0.30	1.51	6.65
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	10.61	1.33	0.44	0.22	1.11
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	8.13	10.16	0.00	0.00	1.36
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	5.11	0.00	0.00	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	14.63	7.32	0.00	0.00	3.66
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	6.61	2.52	0.00	0.00	0.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	9.68	5.75	0.00	0.30	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	11.08	3.16	0.00	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	3.40	2.27	0.00	1.13	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	0.00	0.00	0.00	5.06	10.12
Myoblast, donor1	11241-116D8	7.45	4.47	0.12	0.00	1.61
Myoblast, donor2	11322-117D8	12.08	8.44	0.19	0.58	4.79
Myoblast, donor3	11398-118D3	17.32	5.21	0.00	0.00	1.68
NK T cell leukemia cell line:KHYG-1	10777-110G3	48.30	16.05	0.29	1.17	1.75
Natural Killer Cells, donor1	11230-116C6	114.09	25.52	0.92	1.85	4.31
Natural Killer Cells, donor2	11311-117C6	111.88	25.93	1.21	5.43	5.73
Natural Killer Cells, donor3	11387-118C1	106.57	24.66	0.00	2.39	3.50
Neural stem cells, donor1	11275-116H6	26.13	9.07	0.73	0.00	0.73
Neural stem cells, donor2	11352-117H2	26.96	13.48	0.00	1.93	1.93
Neurons, donor1	11494-119E9	72.83	26.17	0.00	0.00	1.14
Neurons, donor2	11574-120E8	43.15	16.95	0.00	0.22	1.10
Neurons, donor3	11655-122E8	74.82	19.73	1.64	1.64	2.47
Neutrophils, donor1	11233-116C9	714.56	133.63	5.57	30.62	0.93
Neutrophils, donor2	11314-117C9	585.57	95.66	2.90	40.58	0.00
Neutrophils, donor3	11390-118C4	2098.24	197.91	3.67	22.60	4.28
Nucleus Pulposus Cell, donor1	11252-116F1	8.91	9.50	0.00	0.00	1.07
Nucleus Pulposus Cell, donor2	11409-118E5	1.95	3.58	0.00	0.00	0.98
Nucleus Pulposus Cell, donor3	11462-119B4	5.62	8.02	0.00	0.00	0.40
Olfactory epithelial cells, donor1	11933-125I7	14.59	4.40	0.00	0.14	1.93
Olfactory epithelial cells, donor2	11934-125I8	14.04	4.49	0.43	0.43	1.45
Olfactory epithelial cells, donor3	11935-125I9	7.26	2.72	0.23	0.11	2.38
Olfactory epithelial cells, donor4	11936-126A1	10.91	6.43	0.19	0.10	1.46
Oligodendrocyte - precursors, donor1	11496-119F2	17.45	12.64	0.00	0.00	0.60
Osteoblast - differentiated, donor1	11276-116H7	10.42	3.83	0.00	0.00	1.91
Osteoblast - differentiated, donor2	11353-117H3	2.29	4.57	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	4.34	6.21	0.00	0.00	0.62
Osteoblast, donor1	11277-116H8	5.47	7.23	0.00	0.00	3.32
Osteoblast, donor2	11354-117H4	18.96	11.24	0.00	0.00	1.40
Osteoblast, donor3	11426-118G4	11.37	10.31	0.18	0.00	2.67
Pancreatic stromal cells, donor1	11249-116E7	3.79	5.90	0.00	0.17	2.70
Pericytes, donor1	11491-119E6	4.90	9.57	0.11	0.00	0.67
Pericytes, donor2	11571-120E5	12.68	11.77	0.23	0.23	3.40
Pericytes, donor3	11652-122E5	34.99	11.19	0.20	0.00	1.42
Perineurial Cells, donor1	11499-119F5	16.73	7.12	0.34	0.11	2.37
Perineurial Cells, donor2	11579-120F4	6.07	4.42	0.09	0.00	1.10
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	97.53	43.99	0.32	1.59	1.91
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	189.03	28.89	0.24	4.90	6.86
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	188.17	38.18	0.26	2.85	5.56
Placental Epithelial Cells, donor1	11278-116H9	16.98	4.07	0.00	0.00	3.11
Placental Epithelial Cells, donor2	11355-117H5	6.65	4.44	0.00	0.00	1.11
Placental Epithelial Cells, donor3	11427-118G5	6.09	2.75	0.00	0.00	1.18
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	6.01	2.85	0.32	0.32	0.00
Preadipocyte - breast, donor1	11467-119B9	3.75	2.06	0.00	0.00	0.94
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	26.37	1.70	0.26	0.13	2.35
Preadipocyte - breast, donor2	11328-117E5	6.98	2.48	0.23	0.00	1.13
Preadipocyte - omental, donor1	11468-119C1	8.42	2.98	0.00	0.21	0.96
Preadipocyte - omental, donor2	11329-117E6	4.36	5.67	0.00	0.00	1.75
Preadipocyte - omental, donor3	11403-118D8	4.01	4.30	0.14	0.14	1.43
Preadipocyte - perirenal, donor1	11469-119C2	23.62	3.94	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	5.84	9.52	0.00	0.31	0.92
Preadipocyte - subcutaneous, donor2	11356-117H6	4.78	9.03	0.18	0.18	1.06
Preadipocyte - subcutaneous, donor3	11428-118G6	5.45	3.75	0.00	0.00	0.34
Preadipocyte - visceral, donor1	11280-116I2	5.03	7.45	0.00	0.09	1.02
Preadipocyte - visceral, donor2	11357-117H7	12.42	12.89	0.00	0.00	1.38
Preadipocyte - visceral, donor3	11429-118G7	8.57	7.84	0.00	0.00	0.63
Prostate Epithelial Cells (polarized), donor1	11253-116F2	4.98	21.12	0.00	0.45	8.15
Prostate Epithelial Cells, donor2	11331-117E8	62.97	2.84	0.41	0.27	0.54
Prostate Epithelial Cells, donor3	11404-118D9	10.47	3.37	0.18	0.00	2.76
Prostate Stromal Cells, donor1	11254-116F3	1.82	6.38	0.11	0.00	1.25
Prostate Stromal Cells, donor2	11332-117E9	2.69	7.53	0.36	0.00	2.33
Prostate Stromal Cells, donor3	11405-118E1	3.65	7.82	0.00	0.10	1.36
Renal Cortical Epithelial Cells, donor1	11516-119H4	29.20	13.50	0.00	0.00	1.46
Renal Cortical Epithelial Cells, donor2	11596-120H3	24.12	7.21	0.00	0.07	0.62
Renal Epithelial Cells, donor1	11517-119H5	25.36	17.25	0.00	0.00	5.07
Renal Epithelial Cells, donor2	11597-120H4	32.01	10.67	0.00	0.00	5.69
Renal Epithelial Cells, donor3	11678-122H4	23.71	9.21	0.32	0.00	1.80
Renal Glomerular Endothelial Cells, donor1	11514-119H2	15.66	9.53	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	11.32	15.50	0.00	0.00	2.43
Renal Glomerular Endothelial Cells, donor3	11675-122H1	9.99	15.54	0.22	0.22	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	5.99	12.64	0.00	0.00	0.67
Renal Mesangial Cells, donor1	11518-119H6	6.60	12.55	0.00	0.00	1.76
Renal Mesangial Cells, donor2	11598-120H5	11.29	15.67	0.00	0.00	1.25
Renal Mesangial Cells, donor3	11679-122H5	7.77	10.54	0.00	0.00	2.22
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	21.21	19.33	0.27	0.00	1.34
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	21.51	6.33	0.00	0.00	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	17.16	17.74	0.19	0.19	2.12
Retinal Pigment Epithelial Cells, donor0	11215-116A9	9.59	7.78	0.00	0.00	3.89
Retinal Pigment Epithelial Cells, donor1	11528-119I7	3.70	9.95	0.28	0.00	3.41
Retinal Pigment Epithelial Cells, donor2	11608-120I6	8.23	13.38	0.00	0.00	2.06
Retinal Pigment Epithelial Cells, donor3	11689-122I6	1.76	4.27	0.00	0.00	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	42.76	11.36	0.13	0.27	3.21
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	5.36	11.61	0.00	0.00	1.79
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	1.10	7.71	0.00	0.00	2.20
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	4.06	11.02	0.00	0.00	2.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	6.63	14.30	0.00	0.13	2.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	5.06	13.80	0.10	0.00	1.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	5.69	15.62	0.00	0.11	4.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	8.56	10.54	0.12	0.00	2.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	6.76	12.35	0.00	0.23	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	5.32	12.71	0.23	0.00	4.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	8.63	11.23	0.00	0.41	1.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	6.35	15.73	0.00	0.45	2.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	6.09	15.05	0.00	0.00	2.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	11.19	14.35	0.14	0.14	2.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	4.72	14.27	0.00	0.11	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	5.97	13.05	0.00	0.00	3.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	10.51	13.00	0.00	0.00	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	6.24	14.35	0.09	0.00	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	4.70	13.72	0.00	0.19	3.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	11.28	13.27	0.00	0.00	3.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	6.42	13.43	0.00	0.00	1.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	5.16	12.41	0.00	0.19	2.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	12.17	13.99	0.00	0.00	2.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	8.41	10.37	0.00	0.00	2.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	6.67	11.45	0.00	0.00	2.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	8.75	12.22	0.00	0.00	2.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	6.13	12.26	0.12	0.00	2.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	6.98	17.06	0.00	0.13	4.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	13.44	14.86	0.00	0.00	1.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	7.34	12.70	0.20	0.20	1.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	8.65	21.28	0.00	0.00	3.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	8.92	10.78	0.00	0.21	3.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	7.30	13.05	0.00	0.00	2.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	5.85	17.13	0.00	0.00	3.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	8.75	12.52	0.00	0.00	3.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	6.64	14.13	0.00	0.00	4.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	5.59	14.46	0.00	0.00	4.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	6.36	11.00	0.17	0.00	2.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	5.90	13.58	0.00	0.27	4.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	4.10	11.82	0.16	0.16	3.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	4.77	10.40	0.00	0.34	1.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	3.55	9.47	0.00	0.00	2.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	2.13	9.60	0.00	0.00	4.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	4.84	11.20	0.14	0.00	4.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	2.86	13.33	0.00	0.00	2.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	9.07	15.72	0.00	0.00	6.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	8.66	12.53	0.09	0.00	3.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	2.10	8.73	0.35	0.35	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	2.42	10.88	0.30	0.00	4.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	7.59	13.10	0.24	0.12	1.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	3.49	24.89	0.00	0.15	9.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	9.73	17.64	0.00	0.00	3.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	10.25	9.95	0.30	0.30	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	4.75	10.63	0.00	0.00	6.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	8.69	17.97	0.00	1.20	9.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	3.54	11.81	0.12	0.12	4.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	5.34	13.23	0.00	0.00	4.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	5.41	19.23	0.00	0.00	5.41
Schwann Cells, donor1	11498-119F4	9.03	13.54	0.19	0.00	2.44
Schwann Cells, donor2	11578-120F3	6.80	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	11.83	6.13	0.00	0.00	0.88
Sebocyte, donor1	11220-116B5	20.27	9.86	0.00	0.00	1.10
Sebocyte, donor2	11301-117B5	10.11	5.97	0.00	0.00	2.76
Sebocyte, donor3	11378-118B1	19.37	5.57	0.00	0.00	4.12
Sertoli Cells, donor1	11255-116F4	56.32	3.31	0.00	1.66	3.31
Sertoli Cells, donor2	11333-117F1	31.07	5.65	0.00	5.65	2.82
Skeletal Muscle Cells, donor1	11281-116I3	4.13	5.98	0.09	0.26	1.58
Skeletal Muscle Cells, donor2	11358-117H8	7.23	2.89	0.00	0.00	3.61
Skeletal Muscle Cells, donor3	11430-118G8	40.97	24.25	0.00	0.00	5.02
Skeletal Muscle Cells, donor4	11451-119A2	1.41	4.71	0.00	0.16	4.71
Skeletal Muscle Cells, donor5	11455-119A6	2.08	6.09	0.15	0.00	2.68
Skeletal Muscle Cells, donor6	11459-119B1	4.92	13.54	0.00	0.00	1.39
Skeletal Muscle Satellite Cells, donor1	11240-116D7	0.63	4.28	0.00	0.13	6.55
Skeletal Muscle Satellite Cells, donor2	11321-117D7	1.14	5.85	0.00	0.00	4.28
Skeletal Muscle Satellite Cells, donor3	11397-118D2	3.67	9.03	0.10	0.00	4.37
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	3.20	5.14	0.00	0.08	0.67
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	16.65	10.13	0.00	0.00	8.69
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	10.60	8.67	0.14	0.00	1.38
Skin - palm, donor1	10286-104F7	67.15	18.80	0.00	2.69	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	33.01	5.19	0.14	0.00	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	171.76	30.26	0.82	2.45	9.81
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	28.69	6.88	0.00	0.00	1.30
Small Airway Epithelial Cells, donor1	11256-116F5	17.93	3.61	0.14	0.00	2.09
Small Airway Epithelial Cells, donor2	11334-117F2	38.12	3.66	0.00	0.42	1.55
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	143.99	18.82	0.85	0.42	15.01
Small Airway Epithelial Cells, donor3	11406-118E2	41.90	4.27	0.00	0.15	2.55
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	31.17	1.85	0.93	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	68.03	5.56	0.44	0.44	2.89
Smooth Muscle Cells - Aortic, donor0	11210-116A4	55.84	18.22	0.00	0.59	4.11
Smooth Muscle Cells - Aortic, donor1	11283-116I5	23.65	13.04	0.22	0.44	1.10
Smooth Muscle Cells - Aortic, donor2	11360-117I1	12.99	13.78	0.00	0.00	1.18
Smooth Muscle Cells - Aortic, donor3	11432-118H1	57.94	13.91	0.00	0.77	3.09
Smooth Muscle Cells - Bladder, donor1	11519-119H7	1.00	1.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	39.79	7.85	0.00	0.00	1.06
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	7.09	3.32	0.00	0.00	0.66
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	29.45	9.73	0.00	0.13	1.28
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	3.58	5.54	0.00	0.33	3.26
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	0.59	5.32	0.00	0.00	0.89
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	2.28	6.26	0.00	0.00	1.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	1.63	10.57	0.00	0.00	2.44
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	2.44	4.87	0.00	0.00	1.83
Smooth Muscle Cells - Carotid, donor1	11285-116I7	43.69	6.82	0.00	0.00	7.32
Smooth Muscle Cells - Carotid, donor2	11362-117I3	36.72	6.12	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	46.25	13.35	0.00	0.48	0.95
Smooth Muscle Cells - Colonic, donor1	11239-116D6	2.21	6.19	0.00	0.00	1.62
Smooth Muscle Cells - Colonic, donor2	11320-117D6	1.72	6.03	0.00	0.00	1.72
Smooth Muscle Cells - Colonic, donor3	11396-118D1	3.25	8.08	0.10	0.00	2.41
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	14.39	11.29	0.31	0.00	1.08
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	36.65	6.47	0.00	0.00	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	12.85	10.46	0.00	0.00	1.20
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	3.41	13.66	0.00	0.00	3.07
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	5.89	9.03	0.08	0.00	5.03
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	19.02	3.02	0.30	0.10	0.60
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	13.43	10.92	0.00	0.00	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	57.97	17.51	0.00	0.00	3.02
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	2.38	12.72	0.00	0.00	5.30
Smooth Muscle Cells - Prostate, donor1	11257-116F6	2.66	6.79	0.00	0.00	2.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	3.38	5.13	0.13	0.13	2.63
Smooth Muscle Cells - Prostate, donor3	11465-119B7	1.52	4.31	0.25	0.00	0.76
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	22.77	12.82	0.00	0.00	1.66
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	40.51	4.50	0.00	0.00	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	25.84	23.26	0.00	0.00	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	54.88	14.88	0.00	0.00	2.33
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	31.81	7.07	0.50	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	44.50	6.89	0.31	0.00	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	2.95	6.19	0.00	0.00	2.65
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	1.58	8.25	0.00	0.00	2.33
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	0.93	6.54	0.00	0.47	1.40
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	8.49	8.06	0.00	0.00	1.73
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	25.75	13.00	0.00	0.00	3.06
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	27.45	12.41	0.00	0.00	1.69
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	4.89	6.85	0.00	0.28	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	4.61	7.04	0.00	0.00	0.50
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	2.86	6.67	0.00	0.00	1.90
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	14.92	6.12	0.00	0.00	1.71
Smooth Muscle Cells - Uterine, donor1	11258-116F7	10.61	10.16	0.22	0.22	2.87
Smooth Muscle Cells - Uterine, donor3	11466-119B8	10.24	9.07	0.29	0.00	3.51
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	14.19	5.83	0.00	0.00	0.78
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	12.43	2.64	0.53	0.26	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	9.30	2.23	1.12	0.37	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	17.25	8.26	0.00	0.36	2.52
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	3.97	7.95	0.28	0.00	0.85
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	6.70	5.91	0.00	0.00	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	8.63	4.83	0.76	0.25	1.02
Smooth muscle cells - airway, control, donor2	11967-126D5	34.74	7.99	0.40	2.40	1.20
Smooth muscle cells - airway, control, donor3	11968-126D6	17.14	4.60	0.42	1.25	2.09
Smooth muscle cells - airway, control, donor4	11969-126D7	11.92	7.79	0.46	1.83	0.46
Synoviocyte, donor1	11291-117A4	8.25	10.44	0.34	0.00	0.17
Synoviocyte, donor2	11368-117I9	20.28	5.03	0.17	0.17	0.34
Synoviocyte, donor3	11440-118H9	4.02	2.68	0.00	0.45	2.46
Trabecular Meshwork Cells, donor1	11532-120A2	21.44	38.59	0.36	0.00	3.57
Trabecular Meshwork Cells, donor2	11612-122A1	1.98	7.93	0.00	0.00	3.96
Trabecular Meshwork Cells, donor3	11693-123A1	12.50	22.00	0.23	0.00	7.64
Tracheal Epithelial Cells, donor1	11292-117A5	4.09	5.88	0.00	0.00	2.15
Tracheal Epithelial Cells, donor2	11369-118A1	31.31	5.80	0.00	0.00	2.71
Tracheal Epithelial Cells, donor3	11441-118I1	10.31	5.73	0.00	0.00	1.15
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	40.23	14.52	0.25	0.62	3.81
Urethra, donor2	10319-105A4	32.37	19.78	0.00	1.80	3.60
Urothelial Cells, donor1	11520-119H8	17.27	7.70	0.00	0.00	1.59
Urothelial Cells, donor2	11600-120H7	13.22	5.61	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	22.69	6.42	0.23	0.00	1.60
Urothelial cells, donor0	11216-116B1	8.02	6.24	0.22	0.00	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	27.58	64.06	0.00	0.00	6.23
Whole blood (ribopure), donor090309, donation2	12180-129A2	27.16	72.91	0.00	0.00	12.87
Whole blood (ribopure), donor090309, donation3	12181-129A3	14.37	60.92	0.68	0.68	14.37
Whole blood (ribopure), donor090325, donation1	12176-128I7	6.54	43.73	0.00	0.00	7.23
Whole blood (ribopure), donor090325, donation2	12177-128I8	11.62	35.44	0.00	0.00	5.81
Whole blood (ribopure), donor090612, donation1	12182-129A4	57.27	64.56	0.00	0.00	5.21
Whole blood (ribopure), donor090612, donation2	12183-129A5	43.14	46.81	0.00	0.00	8.26
Whole blood (ribopure), donor090612, donation3	12184-129A6	21.00	50.21	0.00	0.00	6.39
Wilms' tumor cell line:G-401	10809-111A8	3.33	9.99	0.12	0.00	3.82
Wilms' tumor cell line:HFWT	10597-108E3	8.80	19.36	0.00	0.00	6.16
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	66.48	17.04	0.28	0.56	1.12
achilles tendon, donor2	10292-104G4	72.33	47.53	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	3.57	13.00	0.25	0.25	8.67
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	8.36	25.77	0.23	0.00	2.79
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	22.44	26.83	0.12	0.83	5.82
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	7.62	27.21	0.27	1.09	20.95
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	0.56	30.08	0.28	0.00	13.49
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	4.65	25.80	0.00	0.00	2.54
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	2.72	31.03	0.54	0.54	3.81
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	11.90	37.01	0.00	0.00	11.90
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	5.72	53.90	0.41	0.41	2.86
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	12.81	22.91	0.00	1.16	8.54
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	0.37	10.86	0.00	0.18	1.66
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	23.40	46.81	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	0.00	34.62	0.70	0.00	3.95
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	1.55	17.61	0.00	0.26	4.66
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	2.05	21.92	0.00	0.29	7.60
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	33.46	10.22	0.46	0.00	4.18
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	18.92	31.26	0.82	0.00	2.47
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	3.99	32.23	0.00	0.00	3.38
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	2.56	17.92	0.00	0.43	8.11
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	2.43	22.44	0.00	0.00	9.71
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	1.44	20.22	0.24	0.00	4.33
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	6.01	26.06	0.00	0.00	6.01
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	0.00	11.34	0.00	0.00	11.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	5.57	11.15	0.00	0.00	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	1.88	21.85	0.38	0.38	1.88
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	4.36	12.21	0.00	0.00	4.80
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	7.50	7.50	0.00	0.00	5.62
adenocarcinoma cell line:IM95m	10796-110I4	10.60	24.02	0.00	0.00	6.12
adipose tissue, adult, pool1	10010-101C1	252.69	38.00	0.31	0.78	6.05
adipose, donor1	10184-103D4	8.80	17.01	0.00	0.00	0.00
adipose, donor2	10185-103D5	161.40	17.03	2.03	3.24	0.00
adipose, donor3	10186-103D6	70.52	10.35	0.54	2.72	2.72
adipose, donor4	10187-103D7	26.00	8.67	0.00	0.87	1.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	2.84	19.73	0.00	0.00	6.15
adrenal gland, adult, pool1	10081-102A9	29.10	14.55	0.00	0.00	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	9.21	5.87	0.13	0.13	5.60
alveolar cell carcinoma cell line:SW 1573	10708-109H6	94.68	21.44	1.07	0.00	3.93
amniotic membrane cells, donor1	12235-129G3	29.44	3.01	0.23	0.23	0.46
amniotic membrane cells, donor2	12236-129G4	11.16	2.70	0.68	0.00	5.07
amniotic membrane cells, donor3	12237-129G5	45.37	1.18	0.29	0.29	1.47
amygdala - adult, donor10196	10167-103B5	143.48	54.55	0.00	2.37	1.19
amygdala, adult, donor10252	10151-102I7	120.44	52.31	0.61	0.81	8.11
amygdala, newborn, donor10223	10360-105E9	35.50	9.04	0.00	3.55	8.07
anaplastic carcinoma cell line:8305C	10428-106D5	43.16	26.10	0.38	2.29	3.57
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	312.62	46.33	3.31	2.43	3.75
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	55.45	0.00	0.00	4.68	8.68
aorta, adult, pool1	10052-101G7	228.10	30.79	0.98	1.96	2.35
appendix, adult	10189-103D9	42.69	37.26	0.00	0.39	15.52
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	1.03	25.80	0.00	0.00	7.91
artery, adult	10190-103E1	116.85	21.74	1.36	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	19.70	36.22	0.29	0.14	0.00
b cell line:RPMI1788	10427-106D4	15.61	8.33	0.00	0.45	2.23
basal cell carcinoma cell line:TE 354.T	10702-109G9	17.48	4.16	0.55	0.28	0.83
bile duct carcinoma cell line:HuCCT1	10432-106D9	5.36	5.76	0.20	0.20	1.49
bile duct carcinoma cell line:TFK-1	10496-107C1	21.59	3.18	0.00	0.33	3.51
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	6.15	10.07	0.00	0.00	1.68
bladder, adult, pool1	10011-101C2	54.54	24.88	0.00	0.43	3.15
blood, adult, pool1	10053-101G8	106.30	17.72	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	8.56	3.43	0.00	0.00	1.71
bone marrow, adult	10192-103E3	81.65	20.92	1.35	2.02	4.05
brain, adult, donor1	10084-102B3	90.21	27.68	0.00	1.03	8.20
brain, adult, pool1	10012-101C3	64.70	29.73	0.45	0.56	3.45
brain, fetal, pool1	10085-102B4	77.47	18.70	0.00	0.00	10.69
breast carcinoma cell line:MCF7	10482-107A5	10.90	20.81	0.33	0.00	3.63
breast carcinoma cell line:MDA-MB-453	10419-106C5	26.96	6.24	0.00	0.00	2.12
breast, adult, donor1	10080-102A8	217.19	44.19	0.63	0.63	4.42
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	52.47	25.66	1.02	0.38	2.03
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	37.11	8.66	0.00	0.00	1.55
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	21.64	5.06	0.46	1.84	0.46
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	3.63	6.78	0.00	0.00	3.63
carcinoid cell line:NCI-H1770	10703-109H1	2.82	4.23	0.47	0.00	0.94
carcinoid cell line:NCI-H727	10735-110B6	9.84	28.66	0.00	0.11	0.98
carcinoid cell line:SK-PN-DW	10719-109I8	14.58	14.58	0.00	0.00	5.70
carcinosarcoma cell line:JHUCS-1	10642-109A3	7.99	9.32	0.27	0.27	3.19
caudate nucleus - adult, donor10196	10177-103C6	321.22	20.72	1.15	9.21	6.91
caudate nucleus, adult, donor10252	10164-103B2	99.73	24.93	1.00	0.50	7.53
caudate nucleus, adult, donor10258	10379-105H1	62.66	18.34	1.53	3.82	5.35
caudate nucleus, newborn, donor10223	10354-105E3	62.99	11.35	0.00	1.83	6.96
cerebellum - adult, donor10196	10173-103C2	93.22	26.22	0.00	0.00	5.83
cerebellum, adult, donor10252	10166-103B4	74.52	33.52	0.00	0.43	12.81
cerebellum, adult, pool1	10083-102B2	50.71	21.04	0.00	1.38	7.59
cerebellum, newborn, donor10223	10357-105E6	52.31	19.10	1.66	0.00	24.91
cerebral meninges, adult	10188-103D8	52.95	26.47	0.76	0.00	1.76
cerebrospinal fluid, donor2	10294-104G6	118.40	31.43	4.39	1.46	2.19
cervical cancer cell line:D98-AH2	10552-107I3	4.17	14.23	0.00	0.14	6.33
cervical cancer cell line:ME-180	10553-107I4	36.79	6.63	0.33	0.83	0.83
cervix, adult, pool1	10013-101C4	21.21	25.72	0.00	0.10	4.93
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	44.17	7.11	0.28	0.42	0.98
chondrosarcoma cell line:SW 1353	10700-109G7	28.74	9.14	0.00	0.00	3.92
choriocarcinoma cell line:BeWo	10423-106C9	2.24	7.95	0.00	0.50	1.74
choriocarcinoma cell line:SCH	10785-110H2	3.94	3.33	0.00	0.00	9.12
choriocarcinoma cell line:T3M-3	10618-108G6	3.56	0.95	0.00	0.00	1.19
chorionic membrane cells, donor1	12238-129G6	58.41	2.28	0.85	0.00	0.85
chorionic membrane cells, donor2	12239-129G7	14.02	8.95	0.10	0.10	1.49
chorionic membrane cells, donor3	12240-129G8	69.24	12.64	2.20	0.55	1.65
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	17.17	11.11	0.00	0.00	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	7.11	31.12	0.00	0.19	6.92
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	1.06	18.58	0.00	0.00	3.38
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	0.00	10.02	0.26	0.00	11.81
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	1.94	14.27	0.00	0.00	14.75
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	0.81	11.61	0.00	0.00	14.86
chronic myelogenous leukemia cell line:K562	10454-106G4	0.29	26.80	0.00	0.00	7.95
chronic myelogenous leukemia cell line:KU812	10409-106B4	14.60	9.38	0.00	0.00	3.65
clear cell carcinoma cell line:JHOC-5	10638-108I8	41.14	5.03	1.14	1.14	2.74
clear cell carcinoma cell line:TEN	10636-108I6	72.18	6.25	0.00	0.17	1.21
colon carcinoma cell line:CACO-2	10513-107D9	9.15	18.85	0.00	0.55	2.20
colon carcinoma cell line:COLO-320	10420-106C6	0.00	14.82	0.00	0.00	5.32
colon, adult, donor1	10082-102B1	14.28	21.42	0.00	0.00	9.52
colon, adult, pool1	10014-101C5	54.40	28.20	0.35	0.00	4.11
colon, fetal, donor1	10070-101I7	64.89	26.57	1.85	1.24	1.85
common myeloid progenitor CMP, donor1	12130-128D6	13.75	210.84	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	25.04	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	35.27	42.49	1.27	0.85	5.52
cord blood derived cell line:COBL-a 24h infection	10453-106G3	13.58	34.87	0.15	0.15	3.77
cord blood derived cell line:COBL-a untreated	10449-106F8	12.83	45.26	0.28	0.14	3.67
corpus callosum, adult, pool1	10042-101F6	292.11	28.41	0.33	2.10	13.82
cruciate ligament, donor2	10295-104G7	110.22	44.58	1.62	2.43	4.05
diaphragm, fetal, donor1	10069-101I6	16.85	23.27	0.00	0.00	4.01
diencephalon, adult	10193-103E4	100.32	15.36	0.24	1.68	4.32
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	13.32	28.01	0.00	0.69	2.76
ductal cell carcinoma cell line:KLM-1	10438-106E6	4.36	2.05	0.00	0.00	1.54
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	7.46	9.63	0.00	0.00	1.93
ductus deferens, adult	10196-103E7	72.26	15.45	1.00	0.50	9.97
duodenum, fetal, donor1, tech_rep1	10071-101I8	21.60	15.84	0.00	0.00	10.08
duodenum, fetal, donor1, tech_rep2	10071-101I8	30.16	13.98	1.47	0.74	7.36
dura mater, adult, donor1	10041-101F5	113.72	38.98	0.17	1.07	1.90
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	25.98	3.55	0.22	0.67	9.55
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	2.72	7.16	0.14	0.00	5.88
embryonic pancreas cell line:1B2C6	10604-108F1	8.63	9.87	0.00	0.00	1.23
embryonic pancreas cell line:1C3D3	10605-108F2	16.35	17.86	0.30	0.00	0.91
embryonic pancreas cell line:1C3IKEI	10606-108F3	8.34	7.72	0.00	0.31	0.93
embryonic pancreas cell line:2C6	10603-108E9	10.51	13.13	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	13.74	1.68	0.34	0.34	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	9.79	19.21	0.72	0.18	2.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	9.33	5.63	0.80	0.16	1.77
epidermoid carcinoma cell line:A431	10426-106D3	25.34	17.56	0.11	0.22	1.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	25.41	9.90	0.22	0.11	2.97
epididymis, adult	10197-103E8	37.47	16.33	0.42	0.21	6.49
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	7.10	7.63	0.18	0.00	1.77
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	7.08	8.26	0.00	0.00	2.75
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	5.37	11.93	0.00	0.00	5.64
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	6.00	9.65	0.00	0.10	7.87
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	4.03	12.44	0.00	0.11	5.83
esophagus, adult, pool1	10015-101C6	30.69	13.80	0.21	0.32	2.44
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	2.50	20.41	0.00	0.00	5.89
eye - muscle inferior rectus, donor1	10272-104E2	65.19	48.29	2.41	0.00	2.41
eye - muscle lateral, donor2	10298-104H1	21.04	27.35	0.00	0.00	10.52
eye - muscle medial, donor2	10299-104H2	25.30	28.28	0.00	0.00	8.93
eye - muscle superior, donor2	10297-104G9	26.37	22.93	0.00	1.15	9.17
eye - vitreous humor, donor1	10268-104D7	94.73	29.15	1.46	0.00	4.37
eye, fetal, donor1	10054-101G9	70.17	7.12	0.00	0.25	2.03
fibrosarcoma cell line:HT-1080	10758-110E2	11.16	18.72	0.13	0.51	0.77
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	19.23	22.79	0.24	0.00	4.04
frontal lobe, adult, pool1	10040-101F4	51.32	45.69	0.09	0.19	4.79
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	15.91	11.71	0.00	1.80	3.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	9.24	7.31	0.00	0.00	1.74
gall bladder, adult	10198-103E9	37.90	17.87	0.00	0.00	5.55
gamma delta positive T cells, donor1	11937-126A2	18.25	18.79	0.00	2.15	16.11
gamma delta positive T cells, donor2	11938-126A3	36.23	21.66	0.00	0.37	8.22
gastric adenocarcinoma cell line:MKN1	10614-108G2	15.63	11.19	0.21	0.00	0.63
gastric adenocarcinoma cell line:MKN45	10612-108F9	4.45	6.00	0.00	0.00	0.58
gastric cancer cell line:AZ521	10549-107H9	2.62	15.74	0.00	0.00	4.10
gastric cancer cell line:GSS	10560-108A2	15.56	34.78	0.00	0.92	10.98
gastrointestinal carcinoma cell line:ECC12	10615-108G3	1.14	0.00	0.00	0.00	0.46
giant cell carcinoma cell line:LU65	10487-107B1	3.44	11.82	0.00	0.00	4.47
giant cell carcinoma cell line:Lu99B	10433-106E1	14.00	12.32	0.28	0.28	2.52
glassy cell carcinoma cell line:HOKUG	10688-109F4	10.23	6.48	0.25	0.00	4.99
glioblastoma cell line:A172, tech_rep1	10444-106F3	6.44	8.87	0.11	0.32	2.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	7.02	7.58	0.00	0.14	2.53
glioblastoma cell line:T98G	10485-107A8	20.31	8.28	0.44	0.55	4.19
glioma cell line:GI-1	10413-106B8	12.89	3.81	0.29	0.59	0.29
globus pallidus - adult, donor10196	10175-103C4	217.94	21.87	0.73	9.48	9.48
globus pallidus, adult, donor10252	10161-103A8	196.01	39.79	0.73	0.73	12.20
globus pallidus, adult, donor10258	10367-105F7	269.73	26.01	0.00	12.32	8.22
globus pallidus, newborn, donor10223	10364-105F4	82.07	8.53	0.00	3.73	4.80
granulocyte macrophage progenitor, donor1	12131-128D7	68.52	154.17	0.00	0.00	9.79
granulocyte macrophage progenitor, donor2	12135-128E2	21.86	32.79	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	26.13	5.23	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	28.16	7.36	0.32	0.00	0.32
hIPS +CCl2, biol_rep1	14383-156B9	12.40	6.89	0.00	0.00	1.84
hIPS +CCl2, biol_rep2	14384-156C1	10.52	5.03	0.00	0.46	2.29
hIPS +CCl2, biol_rep3	14385-156C2	15.46	5.80	0.00	0.64	1.93
hIPS, biol_rep1	14380-156B6	10.06	2.87	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	10.97	4.80	0.00	0.00	2.06
hIPS, biol_rep3	14382-156B8	146.76	7.72	2.21	4.41	1.10
hairy cell leukemia cell line:Mo	10712-109I1	61.20	8.33	0.57	0.29	1.44
heart - mitral valve, adult	10205-103F7	59.20	17.94	0.30	0.60	3.59
heart - pulmonic valve, adult	10206-103F8	30.59	19.09	0.00	0.78	4.45
heart - tricuspid valve, adult	10207-103F9	81.60	44.13	0.00	0.83	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	19.39	8.98	0.20	0.82	3.67
heart, adult, diseased, donor1	10051-101G6	14.90	14.05	0.00	0.43	3.83
heart, adult, pool1	10016-101C7	22.77	16.56	0.00	0.00	1.38
heart, fetal, pool1	10046-101G1	19.10	20.74	0.00	0.10	3.90
hepatic mesenchymal tumor cell line:LI90	10778-110G4	30.24	8.64	0.62	0.62	2.47
hepatoblastoma cell line:HuH-6	10633-108I3	27.35	1.19	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	6.41	0.66	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	7.40	1.94	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	9.90	1.62	0.00	0.00	0.00
hepatoma cell line:Li-7	10484-107A7	34.70	8.01	0.00	0.67	1.67
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	3.42	17.89	0.00	0.00	3.52
hippocampus - adult, donor10196	10169-103B7	174.12	33.12	1.89	5.68	0.95
hippocampus, adult, donor10252	10153-102I9	142.67	35.11	0.61	1.43	7.76
hippocampus, adult, donor10258	10374-105G5	62.24	33.86	1.00	1.00	3.49
hippocampus, newborn, donor10223	10363-105F3	56.04	13.75	0.35	2.47	3.88
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	10.38	10.38	0.00	1.83	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	18.46	12.57	0.20	0.98	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	16.50	10.66	0.00	1.52	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	28.19	32.70	0.00	1.69	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	23.24	35.63	0.26	4.39	2.84
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	20.12	33.79	0.00	1.52	3.42
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	78.24	10.22	0.00	5.55	4.67
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	101.25	6.89	0.43	5.17	4.95
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	50.47	10.01	0.00	0.42	5.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	24.15	3.08	0.00	0.00	3.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	28.61	5.14	0.16	1.13	3.86
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	19.53	6.06	0.00	0.00	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	21.13	8.76	0.16	0.63	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	25.06	10.32	0.49	1.97	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	9.60	7.85	0.00	1.75	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	19.66	37.80	0.00	0.57	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	17.01	26.60	1.31	0.44	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	12.99	20.99	0.00	1.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	100.79	19.59	0.57	3.39	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	132.78	18.64	0.91	1.82	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	101.18	15.98	0.31	0.63	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	19.60	6.21	0.00	0.33	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	24.97	2.90	0.29	0.29	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	21.52	7.17	0.00	0.60	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	14.78	13.12	0.18	1.11	2.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	20.83	10.56	0.57	1.71	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	16.33	8.57	0.00	1.22	1.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	16.55	27.81	0.00	0.70	2.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	14.57	14.57	0.63	1.58	1.58
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	8.78	23.60	0.30	0.30	2.72
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	106.01	10.86	0.00	2.59	3.10
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	105.60	11.29	1.33	0.66	11.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	49.51	10.26	0.51	0.26	4.36
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	23.78	4.09	0.00	0.26	3.83
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	37.10	3.03	0.76	0.76	3.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	16.80	5.38	0.00	0.67	4.70
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	24.63	9.66	0.00	1.69	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	11.14	5.79	0.00	0.89	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	17.07	9.76	0.00	0.49	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	21.70	33.62	0.31	0.31	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	6.51	16.27	0.00	6.51	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	15.22	24.49	0.00	0.00	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	113.29	9.30	0.55	3.28	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	98.43	7.60	0.36	2.17	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	79.00	12.10	0.00	3.20	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	7.16	2.39	0.00	1.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	17.74	3.11	0.00	0.00	0.54
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	15.36	3.23	0.27	0.00	0.27
immature langerhans cells, donor1	11904-125F5	40.92	90.08	1.21	0.24	0.97
immature langerhans cells, donor2	11905-125F6	68.92	117.24	0.00	0.79	3.17
insula, adult, pool1	10039-101F3	69.37	57.44	0.00	0.28	6.25
keratoacanthoma cell line:HKA-1	10791-110H8	42.27	10.40	0.00	1.30	1.95
kidney, adult, pool1	10017-101C8	73.99	7.01	0.30	0.30	3.50
kidney, fetal, pool1	10045-101F9	147.77	14.29	0.00	0.21	7.07
large cell lung carcinoma cell line:IA-LM	10509-107D5	12.36	2.84	0.00	0.14	1.85
large cell lung carcinoma cell line:NCI-H460	10839-111E2	2.21	7.05	0.00	0.00	1.52
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	24.41	10.28	0.00	0.55	4.04
left atrium, adult, donor1	10079-102A7	42.50	5.99	0.00	0.54	1.63
left ventricle, adult, donor1	10078-102A6	19.21	9.10	1.52	0.00	1.01
leiomyoblastoma cell line:G-402	10721-110A1	9.03	15.60	0.00	0.00	6.84
leiomyoma cell line:10964C	10569-108B2	1.80	5.75	0.00	0.00	1.08
leiomyoma cell line:15242A	10570-108B3	7.61	4.89	0.00	0.00	1.09
leiomyoma cell line:15425	10571-108B4	0.97	4.86	0.00	0.00	2.43
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	6.35	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	8.36	10.46	0.00	0.00	2.09
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	9.80	23.26	0.00	0.47	1.65
liposarcoma cell line:KMLS-1	10782-110G8	9.37	5.31	0.00	0.00	1.56
liposarcoma cell line:SW 872	10726-110A6	11.57	8.04	0.00	0.12	0.97
liver, adult, pool1	10018-101C9	27.87	5.83	0.00	0.16	0.97
liver, fetal, pool1	10086-102B5	60.21	4.70	0.94	0.00	1.88
locus coeruleus - adult, donor10196	10182-103D2	175.43	28.00	0.44	2.19	4.81
locus coeruleus, adult, donor10252	10165-103B3	189.90	24.91	0.92	0.92	6.83
locus coeruleus, adult, donor10258	10375-105G6	260.70	16.65	0.28	20.03	3.10
locus coeruleus, newborn, donor10223	10362-105F2	76.97	4.63	1.26	4.63	3.36
lung adenocarcinoma cell line:A549	10499-107C4	23.80	4.57	0.14	0.00	0.69
lung adenocarcinoma cell line:PC-14	10408-106B3	24.82	8.96	0.00	0.00	2.07
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	29.53	12.65	0.00	0.13	2.37
lung, adult, pool1	10019-101D1	79.62	25.04	0.00	0.35	3.07
lung, fetal, donor1	10068-101I5	81.63	29.68	0.57	0.29	9.13
lung, right lower lobe, adult, donor1	10075-102A3	87.98	21.99	0.92	1.83	5.96
lymph node, adult, donor1	10077-102A5	59.64	17.51	0.47	0.95	3.31
lymphangiectasia cell line:DS-1	10727-110A7	34.41	12.49	0.00	0.44	1.32
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	3.92	12.23	0.00	0.00	4.23
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	34.83	6.80	0.00	0.00	1.70
mature adipocyte, donor1	12231-129F8	1253.38	25.31	4.44	1.78	7.10
mature adipocyte, donor2	12232-129F9	673.84	32.58	1.45	0.62	5.81
mature adipocyte, donor3	12233-129G1	794.16	28.92	3.56	1.19	3.79
mature adipocyte, donor4	12234-129G2	828.87	30.53	1.05	1.32	6.05
maxillary sinus tumor cell line:HSQ-89	10414-106B9	2.14	9.05	0.00	0.00	5.96
medial frontal gyrus - adult, donor10196	10170-103B8	66.55	37.23	1.13	1.13	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	100.41	45.24	0.37	0.92	4.97
medial frontal gyrus, adult, donor10258	10368-105F8	56.23	33.67	0.00	2.22	1.59
medial frontal gyrus, newborn, donor10223	10352-105E1	22.60	4.26	0.00	0.85	3.84
medial temporal gyrus - adult, donor10196	10183-103D3	66.49	37.63	0.51	1.86	4.89
medial temporal gyrus, adult, donor10252	10156-103A3	68.34	45.63	0.64	0.42	7.85
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	42.38	30.82	1.93	0.00	3.85
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	28.71	57.41	14.35
medial temporal gyrus, newborn, donor10223	10353-105E2	36.25	4.67	0.00	3.23	5.74
medulla oblongata - adult, donor10196	10174-103C3	221.95	15.58	1.30	4.54	4.54
medulla oblongata, adult, donor10252	10155-103A2	203.41	16.10	0.31	1.39	5.88
medulla oblongata, adult, pool1	10038-101F2	207.17	20.90	0.24	0.82	5.88
medulla oblongata, newborn, donor10223	10361-105F1	95.47	10.42	0.00	2.43	6.25
medulloblastoma cell line:D283 Med	10838-111E1	31.88	32.33	0.00	2.66	6.64
medulloblastoma cell line:ONS-76	10759-110E3	21.28	11.98	0.00	0.12	6.48
melanoma cell line:COLO 679	10514-107E1	6.32	8.34	0.00	0.14	0.29
melanoma cell line:G-361	10465-106H6	11.40	9.50	0.27	0.81	1.09
meningioma cell line:HKBMM	10691-109F7	7.78	11.40	0.00	0.54	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	9.69	3.52	0.00	0.00	11.46
merkel cell carcinoma cell line:MS-1	10844-111E7	0.00	0.00	0.00	0.00	1.04
mesenchymal precursor cell - adipose, donor1	11747-123G1	8.59	5.22	0.15	0.00	0.77
mesenchymal precursor cell - adipose, donor2	11748-123G2	7.09	3.09	0.00	0.00	1.27
mesenchymal precursor cell - adipose, donor3	11749-123G3	1.66	2.48	0.00	0.00	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	15.73	7.73	0.00	0.14	0.56
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	5.97	3.27	0.19	0.00	2.12
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	8.33	4.86	0.00	0.00	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	7.72	2.92	0.00	0.17	1.89
mesenchymal precursor cell - cardiac, donor2	11753-123G7	5.64	1.73	0.12	0.00	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	16.84	4.24	0.00	0.27	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	11.88	5.81	0.14	0.14	1.22
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	31.01	17.21	0.43	0.14	0.43
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	13.83	17.46	0.00	0.33	0.99
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	22.97	13.98	0.28	0.28	0.69
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	15.01	4.54	0.00	0.00	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	14.09	6.33	0.20	0.00	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	32.35	8.63	0.36	0.36	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	16.55	3.93	0.10	0.00	0.31
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	10.94	2.51	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	22.24	5.87	0.42	0.84	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	30.34	12.70	0.15	0.00	0.45
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	17.16	5.78	0.00	0.09	0.18
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	22.83	15.09	0.37	0.37	1.84
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	24.61	10.02	0.00	0.29	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	5.05	4.21	0.00	0.00	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	9.13	3.65	0.00	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	6.14	4.86	0.26	0.00	1.53
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	7.59	4.45	0.00	0.26	2.09
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	6.16	2.16	0.00	0.31	2.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	4.94	3.06	0.00	0.00	1.65
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	6.77	3.38	0.34	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	4.32	1.57	0.39	0.00	1.96
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	2.78	2.78	0.00	0.46	1.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	5.48	4.33	0.29	0.00	2.60
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	5.58	2.23	0.00	0.22	2.01
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	6.25	4.81	0.00	0.00	1.92
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	3.67	2.93	0.00	0.00	2.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	5.37	3.36	0.00	0.00	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	4.50	4.91	0.41	0.00	2.87
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	6.44	2.15	0.00	0.00	3.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	5.47	2.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	5.16	5.16	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	4.87	3.57	0.32	0.32	1.30
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	2.91	2.91	0.00	0.00	2.91
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	2.67	2.67	0.00	0.00	5.33
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	5.72	4.09	0.00	0.00	2.45
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	5.05	3.89	0.00	0.39	1.94
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	4.20	4.20	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	2.98	1.99	0.00	0.00	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	4.77	0.00	0.00	0.00	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	5.34	2.96	0.00	0.00	1.78
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	4.87	1.22	0.00	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	2.53	4.43	0.00	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	1.38	2.41	0.00	0.00	2.76
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	0.00	2.15	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	0.00	0.00	0.00	0.00	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	0.41	1.22	0.00	0.00	2.85
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	0.79	3.18	0.00	0.00	2.38
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	2.36	1.77	0.00	0.00	2.95
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	2.49	2.18	0.00	0.00	5.30
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	2.67	0.00	0.00	0.00	5.35
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	17.74	4.73	0.00	1.18	4.73
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	23.11	7.70	0.00	2.57	5.14
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	20.65	4.82	1.38	0.69	4.82
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	141.02	14.35	1.48	0.99	4.45
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	114.39	10.09	2.24	1.12	6.73
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	141.84	13.99	3.82	0.64	4.45
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	173.69	9.27	1.21	0.40	2.82
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	157.00	4.36	0.00	0.00	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	191.33	12.67	5.07	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	109.24	12.14	0.61	0.61	2.43
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	72.30	18.08	4.52	0.00	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	126.85	5.77	3.29	2.47	4.12
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	25.99	6.35	0.00	0.20	2.18
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	38.61	8.44	0.00	0.32	2.60
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	59.08	5.09	0.00	1.02	3.06
mesodermal tumor cell line:HIRS-BM	10696-109G3	3.87	10.06	0.00	0.00	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	4.96	13.70	0.24	0.24	2.60
mesothelioma cell line:ACC-MESO-4	10494-107B8	6.95	1.16	0.00	0.46	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	4.27	8.55	0.00	0.00	8.55
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	4.83	4.83	0.00	0.00	3.19
mesothelioma cell line:Mero-25	10850-111F4	4.31	8.40	0.00	0.00	3.63
mesothelioma cell line:Mero-41	10851-111F5	5.38	10.02	0.00	0.00	0.98
mesothelioma cell line:Mero-48a	10852-111F6	3.10	9.96	0.00	0.22	4.87
mesothelioma cell line:Mero-82	10853-111F7	1.58	5.52	0.53	0.00	4.99
mesothelioma cell line:Mero-83	10854-111F8	10.04	6.47	0.00	0.00	3.92
mesothelioma cell line:Mero-84	10855-111F9	10.11	5.56	0.25	0.00	1.52
mesothelioma cell line:Mero-95	10856-111G1	2.69	5.59	0.21	0.00	3.73
mesothelioma cell line:NCI-H2052	10847-111F1	3.48	5.47	0.00	0.17	1.82
mesothelioma cell line:NCI-H226	10846-111E9	2.35	1.27	0.18	0.00	2.17
mesothelioma cell line:NCI-H2452	10848-111F2	3.59	2.90	0.00	0.00	2.05
mesothelioma cell line:NCI-H28	10845-111E8	155.48	10.43	1.78	1.53	6.87
mesothelioma cell line:No36	10857-111G2	6.85	12.07	0.00	0.00	3.26
mesothelioma cell line:ONE58	10858-111G3	8.94	19.24	0.54	0.00	2.98
migratory langerhans cells, donor1	11901-125F2	10.94	6.14	0.19	0.19	8.25
migratory langerhans cells, donor2	11902-125F3	24.06	19.05	0.12	0.00	1.59
migratory langerhans cells, donor3	11903-125F4	29.08	17.77	0.72	0.18	3.95
mixed mullerian tumor cell line:HTMMT	10689-109F5	10.45	9.79	0.65	1.63	2.29
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	78.20	2.12	1.27	0.42	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	6.91	19.58	0.00	0.00	3.69
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	11.04	7.23	0.00	0.38	0.57
myelodysplastic syndrome cell line:SKM-1	10772-110F7	3.51	48.05	0.18	0.18	7.02
myeloma cell line:PCM6	10474-106I6	22.53	17.99	0.79	0.00	5.14
myxofibrosarcoma cell line:MFH-ino	10600-108E6	8.62	7.10	0.00	0.00	1.01
myxofibrosarcoma cell line:NMFH-1	10684-109E9	4.51	5.10	0.00	0.00	1.18
nasal epithelial cells, donor1, tech_rep1	12226-129F3	3.01	3.01	0.00	0.00	2.23
nasal epithelial cells, donor1, tech_rep2	12226-129F3	2.57	3.53	0.07	0.00	1.62
nasal epithelial cells, donor2	12227-129F4	17.11	3.86	0.00	0.00	2.21
neuroblastoma cell line:CHP-134	10508-107D4	4.60	24.85	0.00	0.23	0.00
neuroblastoma cell line:NB-1	10539-107G8	10.10	29.56	0.00	0.19	3.93
neuroblastoma cell line:NBsusSR	10607-108F4	6.96	28.89	0.00	0.21	6.54
neuroblastoma cell line:NH-12	10555-107I6	26.09	44.72	0.37	0.75	12.30
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	7.83	12.81	0.24	0.71	9.49
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	30.57	19.01	0.32	0.48	4.43
neuroectodermal tumor cell line:TASK1	10774-110F9	3.42	10.67	0.40	0.00	4.43
neuroepithelioma cell line:SK-N-MC	10728-110A8	7.63	11.44	0.00	0.64	5.09
neurofibroma cell line:Hs 53.T	10729-110A9	21.83	8.52	0.27	0.27	1.86
neutrophil PMN, donor1	12133-128D9	252.87	713.99	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	172.65	159.37	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	189.41	132.59	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	22.32	51.58	0.00	0.68	3.04
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	1.60	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	22.76	10.58	0.00	0.00	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	28.12	9.46	0.26	0.53	1.05
nucleus accumbens, adult, pool1	10037-101F1	85.77	44.34	0.09	0.09	7.03
occipital cortex - adult, donor10196	10172-103C1	74.17	35.03	0.00	2.06	2.06
occipital cortex, adult, donor10252	10163-103B1	153.77	55.55	1.07	0.27	10.20
occipital cortex, newborn, donor10223	10355-105E4	39.67	12.01	0.00	1.09	4.00
occipital lobe, adult, donor1	10076-102A4	52.22	49.86	1.31	2.62	1.57
occipital lobe, fetal, donor1	10073-102A1	54.92	21.03	0.86	0.43	16.73
occipital pole, adult, pool1	10036-101E9	54.16	37.92	0.16	0.08	3.71
olfactory region, adult	10195-103E6	72.60	35.92	0.19	0.38	4.20
optic nerve, donor1	10277-104E7	64.03	36.02	0.00	4.00	14.01
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	63.67	10.02	0.46	0.57	3.42
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	6.32	29.13	0.00	0.14	6.32
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	18.96	1.86	0.17	0.34	0.68
oral squamous cell carcinoma cell line:SAS	10544-107H4	20.79	9.24	0.12	0.35	0.69
osteoclastoma cell line:Hs 706.T	10704-109H2	32.34	4.12	0.29	0.00	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	41.11	30.83	0.00	0.00	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	14.00	18.24	0.00	0.21	1.91
ovary, adult, pool1	10020-101D2	29.87	27.17	0.00	0.35	5.07
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	19.80	9.17	0.00	0.55	0.37
pancreas, adult, donor1	10049-101G4	13.17	22.58	0.00	0.00	10.35
pancreatic carcinoma cell line:NOR-P1	10698-109G5	1.96	2.52	0.00	0.56	2.24
papillary adenocarcinoma cell line:8505C	10437-106E5	6.30	4.94	0.00	0.34	2.04
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	14.24	17.22	0.00	0.17	1.99
paracentral gyrus, adult, pool1	10035-101E8	66.72	50.34	0.00	0.18	4.12
parietal cortex, adult, donor10258	10373-105G4	60.19	22.02	0.00	3.67	2.94
parietal lobe - adult, donor10196	10171-103B9	70.54	32.92	0.94	1.88	4.70
parietal lobe, adult, donor10252	10157-103A4	108.88	52.73	0.57	0.00	5.99
parietal lobe, adult, pool1	10034-101E7	68.91	48.29	0.00	0.26	5.90
parietal lobe, fetal, donor1	10072-101I9	44.61	26.19	0.00	0.97	19.40
parietal lobe, newborn, donor10223	10356-105E5	41.12	8.97	0.75	1.87	4.86
parotid gland, adult	10199-103F1	4.32	4.93	0.00	0.00	1.23
penis, adult	10200-103F2	29.00	16.11	0.00	0.54	5.91
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	73.44	58.01	0.93	1.12	6.69
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	110.58	6.56	0.58	0.44	0.87
pineal gland - adult, donor10196	10179-103C8	26.45	7.74	1.29	1.29	1.94
pineal gland, adult, donor10252	10160-103A7	23.69	3.55	0.00	0.00	5.92
pineal gland, adult, donor10258	10377-105G8	32.61	2.51	0.00	0.63	3.14
pituitary gland - adult, donor10196	10180-103C9	32.38	20.24	0.00	2.02	4.05
pituitary gland, adult, donor10252	10162-103A9	36.48	29.71	0.00	0.00	15.11
pituitary gland, adult, donor10258	10378-105G9	22.13	11.92	0.00	0.85	4.26
placenta, adult, pool1	10021-101D3	10.97	6.45	0.11	0.22	1.18
plasma cell leukemia cell line:ARH-77	10840-111E3	25.16	16.69	0.00	0.53	0.53
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	34.86	17.43	0.47	0.47	2.65
pons, adult, pool1	10033-101E6	95.28	37.35	0.00	0.52	5.16
postcentral gyrus, adult, pool1	10032-101E5	52.13	47.68	0.17	0.35	4.97
promyelocytes/myelocytes PMC, donor1	12132-128D8	56.47	73.20	0.00	0.00	6.27
promyelocytes/myelocytes PMC, donor2	12136-128E3	44.06	22.03	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	11.74	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	19.52	10.92	0.15	0.58	0.87
prostate cancer cell line:PC-3	10439-106E7	7.62	11.98	0.00	0.18	0.54
prostate, adult, pool1	10022-101D4	24.31	16.96	0.00	0.18	4.53
putamen, adult, donor10196	10176-103C5	130.78	24.79	0.47	0.47	5.43
putamen, adult, donor10252	10152-102I8	43.14	19.61	0.00	0.00	5.88
putamen, adult, donor10258, tech_rep1	10372-105G3	48.08	7.65	0.00	1.09	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	72.48	18.36	0.24	0.24	5.32
putamen, newborn, donor10223	10365-105F5	40.48	2.25	0.00	3.00	3.00
rectal cancer cell line:TT1TKB	10469-106I1	6.40	19.78	0.00	0.00	2.33
rectum, fetal, donor1	10067-101I4	43.12	38.95	0.00	0.00	5.56
renal cell carcinoma cell line:OS-RC-2	10411-106B6	93.49	46.43	2.12	0.00	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	137.93	21.54	5.38	3.31	10.36
retina, adult, pool1	10030-101E3	178.22	19.38	0.00	0.80	6.96
retinoblastoma cell line:Y79	10475-106I7	5.98	12.99	0.00	0.00	1.04
rhabdomyosarcoma cell line:KYM-1	10787-110H4	73.77	19.67	0.49	0.49	4.06
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	2.53	5.62	0.00	0.00	1.97
sacrococcigeal teratoma cell line:HTST	10695-109G2	31.83	13.64	0.00	0.76	0.00
salivary acinar cells, donor1	11771-123I7	8.42	6.15	0.00	0.16	1.13
salivary acinar cells, donor2	11772-123I8	1.38	6.75	0.00	0.14	0.55
salivary acinar cells, donor3	11773-123I9	3.31	12.58	0.00	0.66	2.65
salivary gland, adult, pool1	10093-102C3	11.44	10.30	0.00	0.00	5.15
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	0.93	2.95	0.08	0.00	1.10
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	1.18	2.94	0.00	0.24	1.41
seminal vesicle, adult	10201-103F3	46.03	12.17	1.59	3.17	3.17
serous adenocarcinoma cell line:JHOS-2	10639-108I9	7.29	8.50	0.00	0.00	4.37
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	58.38	13.08	1.01	0.50	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	10.04	13.05	0.00	0.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	21.36	6.85	0.27	0.27	5.91
signet ring carcinoma cell line:Kato III	10436-106E4	2.21	16.03	0.11	0.11	1.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	4.52	7.23	0.13	0.00	1.42
skeletal muscle - soleus muscle, donor1	10282-104F3	763.24	48.23	17.02	10.64	0.00
skeletal muscle, adult, pool1	10023-101D5	769.04	52.89	1.32	0.60	1.20
skeletal muscle, fetal, donor1	10066-101I3	13.07	10.05	0.00	1.01	5.03
skin, adult, donor1	10074-102A2	81.42	20.36	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	17.67	13.89	0.00	0.00	5.68
small cell cervical cancer cell line:HCSC-1	10800-110I8	10.34	16.01	0.00	0.00	7.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	18.28	40.03	0.95	2.84	12.29
small cell lung carcinoma cell line:DMS 144	10841-111E4	15.61	24.09	0.19	0.39	3.08
small cell lung carcinoma cell line:LK-2	10541-107H1	7.42	22.58	0.00	0.00	6.26
small cell lung carcinoma cell line:NCI-H82	10842-111E5	10.46	2.73	0.00	0.16	2.73
small cell lung carcinoma cell line:WA-hT	10562-108A4	2.83	10.02	0.00	0.00	3.70
small intestine, adult, pool1	10024-101D6	47.90	24.37	0.24	0.12	4.66
small intestine, fetal, donor1	10064-101I1	18.18	5.41	0.49	0.00	3.44
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	2.05	12.82	0.00	0.00	0.51
smooth muscle, adult, pool1	10048-101G3	18.09	23.00	0.00	0.52	7.50
somatostatinoma cell line:QGP-1	10781-110G7	8.04	10.45	0.00	0.00	6.43
spinal cord - adult, donor10196	10181-103D1	293.87	25.46	0.46	5.28	4.13
spinal cord, adult, donor10252	10159-103A6	393.88	16.56	0.79	3.94	4.73
spinal cord, adult, donor10258	10369-105F9	236.59	6.92	1.38	8.99	1.38
spinal cord, fetal, donor1	10056-101H2	78.67	18.30	1.22	0.61	10.37
spinal cord, newborn, donor10223	10359-105E8	55.56	5.51	0.00	1.38	8.27
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	25.99	3.14	0.30	0.00	0.15
spleen, adult, pool1	10025-101D7	52.64	27.42	0.22	0.11	3.52
spleen, fetal, pool1	10044-101F8	62.69	39.49	0.00	0.32	5.88
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	2.69	1.35	0.00	0.10	3.11
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	37.98	16.52	0.95	0.38	3.99
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	11.53	7.34	0.00	0.35	6.29
squamous cell carcinoma cell line:T3M-5	10616-108G4	13.29	12.90	0.00	0.00	3.13
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	10.69	2.81	0.11	0.34	2.14
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	4.24	13.13	0.00	0.00	5.08
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	1.69	22.42	0.00	0.00	2.54
stomach, fetal, donor1	10062-101H8	30.97	22.43	0.00	0.00	1.07
submaxillary gland, adult	10202-103F4	10.82	11.96	0.00	0.00	12.53
substantia nigra - adult, donor10196	10178-103C7	488.47	54.27	0.00	434.19	0.00
substantia nigra, adult, donor10252	10158-103A5	160.14	31.57	1.66	1.66	8.10
substantia nigra, adult, donor10258	10371-105G2	197.59	14.48	1.55	4.66	2.59
substantia nigra, newborn, donor10223	10358-105E7	103.16	7.77	0.00	8.48	2.83
synovial sarcoma cell line:HS-SY-II	10441-106E9	9.63	31.64	0.46	0.46	0.92
temporal lobe, adult, pool1	10031-101E4	65.10	58.41	0.17	0.08	4.58
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	44.87	10.68	0.00	0.00	30.63
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	33.40	7.91	0.44	0.44	12.31
tenocyte, donor1	11763-123H8	6.63	4.19	0.00	0.35	1.75
tenocyte, donor2	11765-123I1	16.02	5.34	0.00	0.00	1.14
tenocyte, donor3	11768-123I4	4.08	2.22	0.00	0.00	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	43.85	2.21	0.17	0.68	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	56.42	45.94	0.46	0.00	4.16
teratocarcinoma cell line:PA-1	10807-111A6	23.71	6.20	0.62	2.01	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	21.58	8.63	0.00	0.51	1.90
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	11.35	5.67	0.00	0.00	6.81
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	10.80	3.71	0.00	0.22	3.05
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	28.66	6.19	0.00	0.65	2.28
testis, adult, pool1	10026-101D8	32.43	18.04	0.11	0.43	2.47
testis, adult, pool2	10096-102C6	14.43	44.66	0.45	0.45	8.12
thalamus - adult, donor10196	10168-103B6	292.56	16.56	1.10	9.94	5.52
thalamus, adult, donor10252	10154-103A1	149.88	27.35	0.78	0.47	9.38
thalamus, adult, donor10258, tech_rep1	10370-105G1	280.21	4.62	1.54	1.54	3.08
thalamus, adult, donor10258, tech_rep2	10370-105G1	152.50	11.36	0.82	13.83	2.80
thalamus, newborn, donor10223	10366-105F6	37.40	3.45	1.15	2.30	1.73
throat, adult	10209-103G2	30.46	17.23	0.25	0.25	3.99
throat, fetal, donor1	10061-101H7	10.36	8.53	0.30	0.00	9.14
thymic carcinoma cell line:Ty-82	10803-111A2	3.18	50.68	0.60	0.40	7.15
thymus, adult, pool1	10027-101D9	14.32	13.42	0.00	0.00	7.85
thymus, fetal, pool1	10043-101F7	71.90	35.54	0.00	0.21	16.21
thyroid carcinoma cell line:KHM-5M	10776-110G2	10.50	14.23	0.00	1.06	4.92
thyroid carcinoma cell line:TCO-1	10783-110G9	16.06	21.65	0.00	0.70	7.26
thyroid, adult, pool1	10028-101E1	9.52	8.12	0.19	0.09	3.17
thyroid, fetal, donor1	10060-101H6	13.97	11.07	0.00	0.00	12.66
tongue epidermis (fungiform papillae), donor1	10288-104F9	129.34	36.96	0.00	6.16	0.00
tongue, adult	10203-103F5	24.42	13.49	0.00	0.23	0.93
tongue, fetal, donor1	10059-101H5	37.04	9.06	0.00	0.79	5.91
tonsil, adult, pool1	10047-101G2	49.39	25.24	0.10	0.30	6.11
trachea, adult, pool1	10029-101E2	77.38	20.61	0.16	0.16	2.21
trachea, fetal, donor1	10058-101H4	31.54	15.00	0.00	0.38	5.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	7.79	8.15	0.35	0.35	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	32.12	5.27	0.00	0.61	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	4.39	16.77	0.16	0.78	3.29
tridermal teratoma cell line:HGRT	10694-109G1	45.66	9.51	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	19.64	6.94	0.08	0.17	1.69
umbilical cord, fetal, donor1	10057-101H3	39.64	8.35	0.00	2.09	4.17
uterus, adult, pool1	10100-102D1	23.89	25.94	0.00	0.00	7.51
uterus, fetal, donor1	10055-101H1	50.17	15.87	0.00	0.00	6.14
vagina, adult	10204-103F6	38.77	34.89	0.00	0.00	2.58
vein, adult	10191-103E2	40.77	16.66	0.22	0.22	4.16
xeroderma pigentosum b cell line:XPL 17	10563-108A5	6.41	5.07	0.00	0.00	3.20